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Abstract 
Objective diagnosis and therapy evaluation are still challenging tasks for many neurological 
disorders. This is highly related to the diversity of cases and the variety of treatment modalities 
available. Especially in the case of epilepsy, which is a complex disorder not well-explained at the 
biochemical and physiological levels, there is the need for investigations for novel features, which 
can be extracted and quantified from electrophysiological signals in clinical practice. Neurotherapy 
is a complementary treatment applied in various disorders of the central nervous system, including 
epilepsy. The method is subsumed under behavioral medicine and is considered an operant 
conditioning in psychological terms. Although the application areas of this promising 
unconventional approach are rapidly increasing, the method is strongly debated, since the 
neurophysiological underpinnings of the process are not yet well understood. Therefore, verification 
of the efficacy of the treatment is one of the core issues in this field of research. 
Considering the diversity in epilepsy and its various treatment modalities, a concept and a 
methodology were developed in this work for increasing objectivity in diagnosis and therapy 
evaluation. The approach can also fulfill the requirement of patient-specific neurotherapy planning. 
Neuroprofile is introduced as a tool for defining a structured set of quantifiable measures which can 
be extracted from electrophysiological signals. A set of novel quantitative features (i.e., percentage 
epileptic pattern occurrence, contingent negative variation level difference measure, direct current recovery index, 
heart rate recovery ratio, and hyperventilation heart rate index) were defined, and the methods were 
introduced for extracting them. A software concept and the corresponding tools (i.e., the neuroprofile 
extraction module and a database) were developed as a basis for automation to support the 
methodology.  
The features introduced were investigated through real data, which were acquired both in 
laboratory studies with voluntary control subjects and in clinical applications with epilepsy 
patients. The results indicate the usefulness of the introduced measures and possible benefits of 
integrating the indices obtained from electroencephalogram (EEG) and electrocardiogram for 
diagnosis and therapy evaluation. The applicability of the methodology was demonstrated on 
sample cases for therapy evaluation. Based on the insights gained through the work, synergetics was 
proposed as a theoretical framework for comprehending neurotherapy as a complex process of 
learning. Furthermore, direct current (DC)-level in EEG was hypothesized to be an order parameter 
of the brain complex open system. For future research in this field, investigation of the interactions 
between higher cognitive functions and the autonomous nervous system was proposed.  
Keywords: EEG-biofeedback, epilepsy, neurotherapy, slow cortical potentials, objective diagnosis, 
therapy evaluation, epileptic pattern quantification, fractal dimension, contingent negative 
variation, hyperventilation, DC-shifts, instantaneous heart rate, neuroprofile, database system, 
synergetics. 
Zusammenfassung (Abstract in German) 
Die Epilepsie ist eine komplexe neurologische Erkrankung, die auf biochemischer und 
physiologischer Ebene nicht ausreichend geklärt ist. Die Vielfalt der epileptischen Krankheitsbilder 
und der Behandlungsmodalitäten verursacht ein Defizit an quantitativen Kenngrößen auf 
elektrophysiologischer Basis, die die Objektivität und die Effizienz der Diagnose und der 
Therapieevaluierung signifikant erhöhen können. Die Neurotherapie (bzw. EEG-Biofeedback) ist 
eine komplementäre Behandlung, die bei Erkrankungen, welche in Zusammenhang mit 
Regulationsproblemen des Zentralnervensystems stehen, angewandt wird. Obwohl sich die 
Applikationen dieser unkonventionellen Methode erweitern, wird sie nach wie vor stark diskutiert, 
da deren neuro- und psychophysiologischen Mechanismen wenig erforscht sind. Aus diesem Grund 
ist die Ermittlung von Kenngrößen als elektrophysiologische Korrelaten der ablaufenden Prozesse 
zur objektiven Einstellung und Therapievalidierung eines der Kernprobleme des 
Forschungsgebietes und auch der vorliegenden Arbeit. 
Unter Berücksichtigung der aktuellen neurologischen Erkenntnisse und der durch Untersuchungen 
an Probanden, sowie an Epilepsie-Patienten gewonnenen Ergebnisse, wurden ein Konzept und eine 
Methodologie entwickelt, um die Objektivität in der Diagnose und Therapieevaluierung zu erhöhen. 
Die Methodologie basiert auf einem Neuroprofil, welches als ein signalanalytisches 
mehrdimensionales Modell eingeführt wurde. Es beschreibt einen strukturierten Satz 
quantifizierbarer Kenngrößen, die aus dem Elektroenzephalogramm (EEG), den ereignisbezogenen 
Potentialen und dem Elektrokardiogramm extrahiert werden können. Als Komponenten des 
Neuroprofils wurden neuartige quantitative Kenngrößen (percentage epileptic pattern occurrence, 
contingent negative variation level difference measure, direct current recovery index, heart rate recovery ratio, 
hyperventilation heart rate index) definiert und die Methoden zu deren Berechnung algorithmisiert. Die 
Anwendbarkeit der Methodologie wurde beispielhaft für die Evaluierung von Neurotherapien an 
Epilepsie-Patienten demonstriert. Als Basis für eine zukünftige Automatisierung wurden ein 
Softwarekonzept und entsprechende Tools (neuroprofile extraction module und die Datenbank 
„NeuroBase“) entwickelt. Der Ansatz erfüllt auch die Anforderungen der patientenspezifischen 
Therapieplanung und kann auf andere Krankheitsbilder übertragen werden.   
Durch die neu gewonnenen Erkenntnisse wurde die Synergetik als ein theoretischer Rahmen für die 
Analyse der Neurotherapie als komplexer Lernprozess vorgeschlagen. Es wurde die Hypothese 
aufgestellt, dass das Gleichspannungsniveau im EEG ein Ordnungsparameter des Gehirn ist, wobei 
das Gehirn als ein komplexes offenes System betrachtet wird. Für zukünftige Forschungen auf dem 
Gebiet wird empfohlen, die Wechselwirkungen zwischen den höheren kognitiven Funktionen und 
dem autonomen Nervensystem in diesem Kontext zu untersuchen.  
Schlüsselwörter: EEG-Biofeedback, Epilepsie, Neurotherapie, langsame kortikale Potentiale, 
objektive Diagnose, Therapieevaluierung, epileptische Musterquantifizierung, Fraktal Dimension, 
Kontingent negative Variation, Hyperventilation, DC-Verschiebung, momentane 
Herzschlagfrequenz, Neuroprofil, Datenbanksystem, Synergetik. 
Özet (Abstract in Turkish) 
Birçok nörolojik bozuklukta, vak’aların ve tedavi yöntemlerinin çeşitliliği, nesnel tanı ve tedavi 
değerlendirmelerini güçleştirmektedir. Özellikle epilepsi gibi, gerek biyokimyasal gerekse fizyolojik 
düzlemlerde yeterince açıklanamamış rahatsızlıklarda, elektrofizyolojik sinyallerden elde 
edilebilecek yeni nesnel parametrelere ihtiyaç duyulmaktadır. Davranışsal tedavi olarak 
sınıflandırılıp psikoloji terimiyle ‘aletli koşullanma’ olarak tanımlanan nöroterapi, epilepsi de dahil 
olmak üzere merkezi sinir sisteminin regülasyon bozukluklarında kullanılan bir yöntemdir. 
Uygulama alanları giderek yaygınlık kazanmakla birlikte, nörofizyolojik temelleri henüz açıklık 
kazanmadığından, bu yöntemin geçerliliği büyük ölçüde tartışılmaktadır. Dolayısıyla, nöroterapinin 
etkinliğinin saptanması bu araştırma alanının önemli konularındandır.  
Bu çalışmada, epilepsi hastalığının ve tedavi yöntemlerinin çeşitliliği göz önünde tutularak, tanı ve 
tedavi değerlendirmelerinde nesnelliği artırmak amacıyla yöntem ve araçlar geliştirilmiş, yeni 
parametreler tanımlanmıştır. Elektorfizyolojik sinyallerden elde edilebilecek nicelikler kümesini 
içeren matematiksel bir araç olarak ‘Nöroprofil’ kavramı tanımlanmıştır. Nöroprofilin bileşenlerinin 
bir alt kümesi olarak yeni parametreler (epileptik örüntü sıklığı, bağıl negatif değişim düzeyi ölçüsü, 
hiperventilasyonda doğru akım değişim göstergesi, hiperventilasyonda nabız değişim oranı ve nabız göstergesi) ve 
bu parametrelerin hesaplanma yöntemleri ortaya konulmuştur. Geliştirilen yöntemlerin 
otomasyonunu sağlayabilecek yazılım araçları (nöroprofil çıkarım modülü ve veri tabanı) geliştirilmiştir.  
Tanımlanan parametreler, gerek epilepsi hastalarından gerekse gönüllü katılımcılardan elde edilen 
sinyallerle hesaplanmış ve karşılaştırılımıştır. Sonuçlar, bu parametrelerin tanı amaçlı 
kullanılabilirliğini göstermektedir. Özellikle hiperventilasyon sonucu EEG ve EKG sinyallerinde 
meydana gelen degişimleri niceliklendirmek için tanımladığımız göstergelerin birleşik analizi yeni 
bir yöntem olarak önemli sonuçlar vermiştir. Geliştirilen yöntemler, tedavi değerlendirilmesi amaçlı 
örnek vak’alarda kullanılmıştır. Çalışmalarda elde edilen gözlem ve sonuçlar doğrultusunda, 
karmaşık bir öğrenme süreci olarak nöroterapinin daha iyi anlaşılabilmesi için yeni bir düşünce 
sistematiğininin gerekliliği tartışılmıştır. Sinerjetik yaklaşımın bu alanda teorik bir çerçeve sağladığı 
öne sürülmüştür. Bu açıdan, EEG’nin doğru akım bileşeninin, beyin karmaşık açık sisteminin bir 
‘düzen parametresi’ olduğu hipotezi ortaya atılmıştır. Bu alandaki bilimsel çalışmaların, beynin 
bilişsel işlevleri ve otonom sinir sistemi arasındaki etkileşimlere yoğunlaştırılması önerilmiştir. 
Anahtar Sözcükler: EEG-biyogeribildirim, epilepsi, nöroterapi, yavaş kortikal gerilimler, nesnel 
tanı, tedavi değerlendirilmesi, nöroprofil, veri tabanı, epileptik örüntü nicelendirilmesi, fraktal 
boyut, bağıl negatif değişim, hiperventilasyon, doğru akım kayması, anlık nabız, sinerjetik.  
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1 Introduction 
Biofeedback is an unconventional method introduced for the treatment of diverse 
disorders related to regulation problems in human physiology. The method, which is 
defined as a process of learning (i.e., operant conditioning), and subsumed under 
behavioral medicine, is based on the capability of learning to bring the physiological 
functions under voluntary control. If the physiological function under consideration is a 
brain function, then terms such as operant brain regulation, cortical self-regulation or 
neurofeedback are utilized.  
Parallel with developments in computer technology and on-line signal processing in 
recent decades, neurofeedback treatment, which is often referred to as neurotherapy, 
has enlarged its fields of application beyond the more historically established research 
in treatment of epilepsy and attention deficit hyperactivity disorder (ADHD).  
Research in this field has many facets and needs highly interdisciplinary cooperation: 
On the one hand, psychologists and neurologists search for new protocols, investigate 
their applicability in different disorders, and try to explain the underlying neuronal 
mechanisms. On the other hand, engineers work on the development of new brain-
computer-interface (BCI) systems which can comply with the requirements of high 
flexibility and adaptability. The present state of investigations shows that, in order to 
achieve success in neurotherapy, patient-specific clinical manifestations have to be 
considered for adapting the learning process according to the subject’s individual 
characteristics  
In our studies at the Technische Universität Ilmenau, the Institute of Biomedical 
Engineering, we (i.e., the NeuroCybernetics Research Group (NCRG) [1]) have 
developed a prototype of a flexible BCI system which can also be employed for 
neurofeedback applications for different disorders [2]-[4]. Using this system we held 
training sessions with healthy controls and clinical applications with refractory 
epilepsy patients. The training sessions were based on the self-regulation of the so 
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called slow cortical potentials (SCP). These are slow potentials (SP) recorded on the 
scalp which include direct current (DC) and near DC components.  
The present work does not focus on the developed BCI system5, but on two other issues 
in the research field, namely, (1) a patient-specific neurotherapy strategy, and (2) an 
objective, possibly automated, evaluation of the applied therapy. The problem in 
objective evaluation, as in other medical treatment processes, is concentrated in the 
determination and quantification of the changes resulting from therapy by means of 
pre- and post-therapy comparisons. The prerequisite for these comparisons is, however, 
the determination of features which distinguish a certain pathological state from 
normal functioning. The issue of patient-specific neurotherapy can similarly be 
addressed by means of quantitative features which reflect the neurophysiological 
differences between the individuals. 
The neurometric quantitative electroencephalogram (qEEG) analysis, as defined in   
[5]-[8], appears to be a possible tool for solving this problem. However, in epilepsy, as 
in several other neurological disorders, the qEEG cannot be considered apart from 
additional medical information, such as the results of the clinical examination, medical 
history, previous and current pharmacological and other (e.g. surgical) treatments, and 
further disorder specific information. Especially in case of refractory epilepsy patients 
with a long history of the disorder, it is necessary to include all accessible information 
for the evaluation of the therapy. Additionally, the therapy specific information 
regarding its modalities must be considered. For pharmacological treatment, this can be 
the active substance, its daily doses and the time span of prescription. For 
neurotherapy, it is essential to access information such as  
? the feedback parameter (i.e., frequency bands, slow cortical potentials etc.),  
? the stimuli used for the task definition (i.e., visual, acoustic or tactile),  
? the feedback used (i.e., visual or acoustic),  
? the duration and number of trials, and  
? the information related to the simultaneously acquired polygraphical signals.  
                                                         
5 The BCI system has been awarded with the German Innovation Award 2004 for Biomedical 
Engineering given by the “Stiftung Familie Klee”.  
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All these necessities yield an excessive amount of data which need to be structured and 
managed. This is one of the components of the problem solved via a software concept 
linked to a data warehouse in this study.   
The scope of the problem, however, extends far beyond this aspect alone, because in 
many epilepsy cases there is no significant deviation from the normal neurometric 
qEEG values. The present state of investigation reflects a very high individual diversity. 
Due to the lack of distinguishing features, epilepsy cannot be clustered in any existing 
normative qEEG database. Hence, in order to evaluate and validate the success of 
neurotherapy in epilepsy, there is the need for a better understanding of both 
neurotherapy as an emerging unconventional treatment and of epilepsy as an 
inadequately explained disorder. From this perspective, the problem extends over the 
disciplines of psychology, neurology and engineering.  
For this reason, an overview of the conventional medical fundamentals of epilepsy and 
of the two main neurotherapy protocols proposed for epilepsy treatment is provided in 
chapter 2. The SCP based neurotherapy is described in more detail, since it is the 
clinically applied protocol in the current study. In the same chapter, the DC potentials 
associated with diverse states of the brain are introduced in order to complete the 
basics necessary for problem orientation and analysis.  
After a critical analysis of the interdisciplinary issue with its biomedical engineering 
aspects and roots in both neurology and psychology, the guidelines for a possible 
solution are sketched in chapter 3.   
In chapter 4, associated with the developed therapy evaluation strategy, the concept of 
neuroprofile is coined, and the protocol for the initial and evaluation measurements, 
which is determined in consultation with medical partners, is presented. 
A separate chapter (chapter 5) is dedicated to data acquisition, since the measurements 
in both healthy controls and epilepsy patients constitute a significant part of the study. 
In this chapter, the equipment, including the developed BCI system and the technical 
settings of the measurements, is introduced shortly. The laboratory studies with 
voluntary control subjects and the clinical applications with epilepsy patients, which 
involve learning and training the self-regulation of the central or frontocentral SP, are 
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presented along with the corresponding details of the acquired electrophysiological 
signals.  
Chapter 6 comprises the signal analytical methodology developed or, respectively, used 
for extraction and quantification of the selected feature candidates. The unsupervised 
and supervised approaches are introduced for quantifying epileptic patterns 
(i.e., graphoelements) in electroencephalogram (EEG). The procedures for analyzing 
contingent negative variation (CNV), as well as hyperventilation induced DC-shifts in 
EEG and changes in simultaneously acquired electrocardiogram (ECG) are presented.  
The data management component of the solution is addressed in chapter 7. The 
developed software concept and the corresponding database system are introduced 
with their implementations. 
Chapter 8 presents the essential results of signal analysis, comparisons between healthy 
controls and epilepsy patients, as well as sample pre- and post- therapy comparisons 
for the patients who were available for follow-up.  
After this overview of the obtained results, the thesis continues with a detailed 
discussion in chapter 9. Based on the essentials of the results, the discussion focuses on 
the necessity of a change in paradigm for understanding neurotherapy and its effects in 
epilepsy, in order to comprehend a complex process of operant conditioning (i.e., 
neurotherapy as a process of learning) which elicits alterations on a very complex 
system: The human brain with its more than 100 billion neurons, 104 connections per 
neuron, and 1022 molecules per cubic centimeter is a giant dynamical system [9]. The 
neurofeedback process, on the other hand, is a voluntary intervention with the central 
nervous system (CNS) at a macroscopic level and involves both psychological and 
neurological processes. At this point, the discussion reaches to the depth of the 
philosophical mind-body problem. Even though the problem appears to be very 
complicated, changing our paradigm and using new concepts such as open systems, 
self-organization, circular causality and synergy, which are the foundations of synergetics 
as coined by Haken [9], [10], lead us to new possible approaches, which should be a 
subject of further research in the field. From this perspective, not only neurotherapy 
and epilepsy but also the SP on the scalp gain new meaning. 
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In chapter 10, conclusions are derived and future research directions are proposed 
based on new perspectives obtained from synergetics. A new path concentrating on 
parameters, which shall and can reflect functional couplings between the participating 
subsystems in the neurofeedback process (e.g., the higher cognitive functions and the 
autonomic nervous system), is proposed for further investigations in both epilepsy 
research and objective (neuro)therapy6 evaluation.  
                                                         
6 The form with parentheses is used for the term (neuro)therapy in order to emphasize that the results and 
conclusions in terms of engineering, as well as in terms of psychology and neurology, achieved in this 
work can also be employed for other therapies in epilepsy. 
2 Fundamentals: Epilepsy and EEG-Biofeedback 
In order to have a point of reference for the issues of patient-specific neurotherapy 
strategy and objective (neuro)therapy evaluation in epilepsy, it is necessary to have an 
overview on the disease, its therapies and corresponding treatment modalities. These 
will be summarized in this chapter. 
2.1 Epilepsy 
"A disease of the nervous system, characterized (in its severer forms) by violent paroxysms, in which the 
patient falls to the ground in a state of unconsciousness, with general spasm of the muscles and foaming 
at the mouth."  
The above description of the Oxford English Dictionary is also the common public 
imagination of an epileptic seizure. A “generalized seizure” is, however, only one of the 
categories of possible epileptic symptoms. One can even prefer to consider the term 
“epilepsies” representing the plurality of the forms of the disorder [11], [12]. Epilepsies 
are characterized by the episodic recurrence of paroxysmal neurological or behavioral 
manifestations caused by abnormal synchronous and excessive discharges of large 
groups of neurons. In this chapter, the term “epilepsy” will be used as a genus for the 
group of diseases and syndromes of which the common feature is the occurrence of 
epileptic seizures.   
2.1.1 Clinical Features 
The incidence of human epilepsy is estimated to range between 0.5 and 1% of the 
general population. After disorders of circulation, epilepsy is the most frequent chronic 
disorder of the nervous system [11], [13].  
Epilepsy is not a unitary disease. It varies not only in etiology, but also in seizure types 
and accompanying somatic and/or psychic symptoms, as well as in the course of 
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occurring seizures. The differential diagnosis of epilepsy must consider other episodic 
disturbances of CNS functions such as syncope, migraine, hysteria, and other 
psychiatric disorders, and determine whether the seizures are caused by a structural 
brain lesion, a metabolic derangement, or a genetically determined brain disorder [14].  
In fact, epilepsy is a multi-factorial condition reflecting acquired and genetic factors. 
Factors such as prenatal and postnatal cerebral trauma, infections of the CNS, brain 
tumors, cerebral vascular lesions, congenital malformations, and some metabolic 
disorders can be listed as possible exogenous factors. Such epilepsies, for which an 
exogenous factor is identifiable, are defined as symptomatic epilepsy. Identification of 
the exogenous factors involved in the causation of epilepsy is relevant for its 
prevention, since the incidence of disorder can be reduced by prenatal care or by 
prevention of brain injuries. The idiopathic epilepsies, on the other hand, are those 
which have genetic factors as an identifiable cause. These may include seizures caused 
by a single gene disorder (e.g., some inborn errors of metabolism) and other genetic 
factors that interact with exogenous factors. In some forms of inherited seizure 
disorders in animals, significant progress has recently been made in understanding their 
molecular biology. In many epilepsy cases, however, the etiology remains unknown. 
Therefore, a large group of epilepsies is classified under the term cryptogenic 
epilepsy [14]. 
2.1.2 Focal (Partial) and Generalized Epilepsy 
Epileptic discharges may involve any structure of the CNS, although they usually 
originate in some of them (most often the cerebral cortex, including the hippocampus, 
or the amygdala) [14]. The most dramatic clinical manifestation is loss of consciousness 
with generalized tonic-clonic convulsions (i.e., a generalized seizure), which actually 
may be the final outcome of any epileptic seizure, but particular seizures exhibit a great 
variety of clinical signs and symptoms. Their distinctive features depend upon 
differences in the site of origin and in the extent and pattern of spread of the seizure 
discharge. Thus, the symptomatology of an epileptic seizure reflects the functional 
significance of the brain area involved in the seizure discharge. For instance, twitching 
of the left or right facial muscles can be associated with discharges involving the 
contra-lateral face area of the precentral gyrus, or phosphenes occurring in the visual 
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field with discharges in the contra-lateral visual cortex, or evocation of past memories 
can be related to discharges in temporal lobe. Such symptoms result from ictal 
activation of neuronal mechanisms represented in the corresponding areas, whereas 
other manifestations such as the inability to utter or understand speech result from 
disruption of the normal function of the speech cortex when this area is involved in 
ictal discharge [14]. 
Depending on whether the brain is entirely or only partially involved in a seizure 
discharge at its onset, which is evaluated by both clinical and EEG criteria, epileptic 
seizures are subdivided into two main categories: (1) partial (i.e., focal) and (2) 
generalized. Each category is further subdivided into subcategories according to the 
ictal symptoms of the seizure [12]-[14]. The International League Against Epilepsy 
(ILAE) classifies epileptic seizures mainly as (1) focal, (2) complex focal, (3) secondary 
generalized, and (4) (primary) generalized seizures [15]-[16]. Although epilepsy 
classification has various aspects and is much more complicated, the separation as focal 
and generalized will be taken as a basis in this work, since focal epilepsy patients are 
considered as more suitable for neurotherapy. 
2.1.3 The Neurophysiology 
Although the biochemical mechanisms are not yet clearly explained, certain typical 
electrical phenomena are observed in epilepsy. Intercellular measurements at epileptic 
foci show an extraordinary long lasting, high amplitude membrane depolarization 
accompanied with spike trains. This phenomenon is defined as paroxysmal 
depolarization shift (PDS). This was first described in neurons lying under 
experimentally induced foci. The long-lasting depolarization corresponds to epileptic 
discharges observed at surface electrodes. There may be various mechanisms or 
combinations of them promoting this phenomenon:  
a. decreased inhibition (insufficient gamma-amino butyric acid –GABA),  
b. increased excitation (derangement in N-methyl-D-aspartate (NMDA) receptor 
and glutamate),  
c. alterations in Na+, Ca+, K+  ion concentrations, or  
d. alterations in membrane ion channels.  
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Mechanisms of kindling (i.e., long-term sub-threshold stimulation giving rise to 
persistent primary and secondary foci) and long-term potentiation (LTP) 
(i.e., modification of synaptic activity upon synchronously recurrent firing), which are 
addressed for memory and learning processes in normal brain functioning, are also 
considered for their involvement in epileptogenesis [17]. 
2.2 Therapies in Epilepsy 
The objective of any epilepsy therapy is that the patient becomes seizure free, or at least 
a significant reduction in the frequency and/or intensity of seizures is aimed with the 
least possible physical and psychological disruption for the patient (i.e., side effects). 
The therapies offered in epilepsy today can be listed as: pharmacological, surgical, 
alternative and behavioral therapies. 
2.2.1 Pharmacological Therapy 
Traditionally, the first choice in epilepsy treatment is pharmacological therapy. Based 
on the possible biochemical mechanisms presumed, different anti convulsive 
substances are offered in pharmacological therapy. These aim at acting on the 
corresponding biochemical components such as the ion balance of the neuronal 
environment through either  
a. changing the ion concentrations or the permeability of the neuronal membranes 
to certain ions such as K+, Na+, Ca+ (i.e., Type A medication: carbamazepine, 
phenytoin, lamotrigine); or  
b. increasing the inhibition (GABA energic) (i.e., Type B medication: valproate, 
benzodiazepine, vigabatrin, tiagabin); or  
c. decreasing the excitation (acting on NMDA-receptor/glutamate) (i.e., Type C 
medication: NMDA-antagonist, losigamon, dextromethorphan, felbamat, 
gabapentin) [18].  
The pharmacological therapy in epilepsy has two main problems: First is pharmaco-
resistance (i.e., refractory epilepsy patients) of a significant percentage of the patients 
(i.e., 25%), and the second is the strong side-effects of the medication on both organic 
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(e.g., hepatic side effects) and psychophysiological (e.g., perceptive and cognitive side 
effects) levels [19]. 
2.2.2 Surgical Therapy 
Surgical treatment is the second choice in mainly intractable focal epilepsy cases for 
which the focus can be precisely determined, so that it can be removed by a surgical 
operation. It is also applied to remove larger brain areas or to severe the corpus 
callosum so that communication between the cerebral hemispheres is interrupted (i.e., 
callosotomy). Due to the problems with focus localization and the high risks of surgical 
intervention, this treatment can be applied to a rather small group (20%) of patients 
with refractory epilepsy [20]. 
Vagus Nerve Stimulation 
Another relatively new treatment, which can be classified under surgical therapy, is 
vagus nerve stimulation. In this treatment an electrical pacemaker is implanted into the 
body in order to stimulate the vagus nerve at different frequencies, which result in an 
increased desynchronization in EEG. It can be applied in severe intractable epilepsy 
cases and may be a possible alternative to callosotomy. However, it is contraindicated 
for patients with obstructive lung or heart diseases [21]. 
2.2.3 Alternative Therapies 
There are other treatment approaches which can be summarized under the term 
alternative treatment. In this category, therapies such as diet, acupuncture or yoga can 
be listed [22]. 
2.2.4 Behavioral Approaches  
The behavioral approaches for seizure control arise mainly from studies in psychology 
and learning rather than neurology, and are based on the concept that the seizures 
occur as a reaction to certain environmental stimulants or as reinforced behavior. These 
approaches are also considered for treatment as a second choice, if no success is 
achieved in pharmacological treatment.  
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In these approaches, both the brain electrical activity and its clinical manifestations 
during seizures are considered as behavior, which is influenced by both external stimuli 
and internal contingence, from a learning theoretical perspective [23]. The episode of a 
seizure is viewed in its temporal structure with its prodromi, aura, seizure and post-
ictal phases. The antecedent events and initiating stimuli are defined and consequently, 
the seizure facilitating conditions are specified. Correspondingly, by means of classical 
and operant conditioning, an alteration not only in behavioral components but also in 
contingencies are sought. In this context, several approaches are studied. These involve 
modification of, (1) external and internal seizure supporting stimuli and reactions, 
(2) seizure facilitating contingencies, (3) the motion of the limbs participating in the 
behavior chain of the seizure, and (4) electro-cortical processes [23].  
Desensibilization therapy in reflex epilepsies caused by certain visual, acoustic, 
olfactory or tactile stimuli, psychological self-control programs in which the patients 
learn to perceive the seizure facilitating factors via self-observation, and EEG-
biofeedback belong to behavioral approaches in epilepsy treatment. 
2.3 Neurotherapy in Epilepsy 
Biofeedback is the method of feeding back a quantitative parameter of a physiological 
function of the body to the perception of a subject through artificial equipment so that 
the person learns to control the quantitative parameter voluntarily. Consequently, it is 
expected that the subject gain the skill of controlling the physiological dynamics 
generating the given parameter which otherwise proceed unconsciously.  
If the quantitative parameter is obtained from the brain electrical activity (e.g., EEG), 
then it is defined as EEG-biofeedback, neurofeedback [24], learned cortical self-
regulation [25]-[27], or operant brain regulation [28], [29]. The therapeutic 
applications of EEG-biofeedback are commonly referred to as neurotherapy [30].  
Studies of the operant control of EEG components go back to the 1960s. An alpha 
rhythm feedback study was first published in 1969 [31]. Since then, EEG-biofeedback 
has enlarged its protocols as well as its application spectrum beyond the treatment of 
epilepsy and ADHD. Like other biofeedback approaches (i.e. self-regulation of heart 
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rate, blood pressure, galvanic skin response, finger tip temperature etc.), the method is 
subsumed under the term behavioral medicine. The different approaches, which use 
different EEG components, vary basically in the physiological relevance of the extracted 
quantitative parameter.  
In epilepsy, two main protocols of neurotherapy are singled out: the sensorimotor 
rhythm (SMR) studies and SCP studies:  
2.3.1 Sensorimotor Rhythm Studies 
Conditioning of certain frequency bands of EEG and its effects on seizure frequency 
and intensity was initially examined by Sterman [32], [33] and Lubar [34]. The term 
SMR, which refers to the activity between 12-15 Hz in EEG over the sensorimotor 
cortex and is associated with motoric inactivity, was first coined by Sterman during his 
studies with cats [35]. The findings in the animal experiments and measurements on 
the sensorimotor cortex of the cats during different states of sleep showed that the 
SMR activity occurs as a consequence of increased recurrent inhibition and blockage of 
over-excitation in the thalamus [35], [36]. The possible seizure preventing benefit of 
SMR-feedback was also observed during the same studies [35]-[38].  
Significant seizure reductions following the SMR feedback training were reported by 
Sterman [32], [33], by Lubar and Bahler [34], and by Finley et al. [39]. In [34], the 
feedback protocol included increasing the SMR activity and suppressing the slower 
(3-7 Hz) frequency activity at the same time. The protocol was applied at central brain 
regions. In 50% of the patients, a 35-50% seizure rate reduction was observed. 
Additionally, a normalization of sleep EEG, especially in the patients with abnormal 
sleep-EEG patterns, e.g., absence of sleep spindles, was observed. According to [37], 
Wyler et al. [40], who provided a reward for higher frequencies in the central cortical 
EEG (14-26 Hz), reported similar successful seizure reduction. 
2.3.2 Slow Cortical Potentials Studies 
The second protocol of neurotherapy applied in epilepsy is based on SCP. SCP, which 
are often referred to as DC-shifts [41]-[44] and studied in various contexts under 
different provocations and paradigms,  are the shifts observed in the EEG-baseline 
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(Fig. 2.1), which can last from seconds to minutes [23], [29], [41], [44]. Although there 
is no consensus on the origin and generation mechanism of these potentials, they are 
reported to be fundamental in diverse states of the brain and are accepted to be 
indicators of cortical excitability [29], [43], [44].  
 
Fig. 2.1 EEG and DC/EEG. Principles of wave generation. The excitatory synapses of two afferent fibers contact 
the superficial dendritic arborisation of two longitudinal neuronal elements. The afferent fiber activity is 
recorded by means of the intracellular electrodes E1 and E2, and the membrane potentials (MP) of the 
dendritic elements are recorded by the electrodes E3 and E4. The field potential at the surface of the 
neuronal structure (cortex) is led by the electrode E5. Synchronized groups of action potentials in the 
afferent fibers (E1, E2) generate wavelike excitatory postsynaptic potentials (EPSPs) in the dendritic 
areas (E3, E4) and corresponding field potentials in the EEG and DC/EEG recording (E5). Tonic activity 
in the afferent fibers results in a long-lasting EPSP with small fluctuations. During this period the EEG 
(5b) shows only a reduction in amplitude, whereas the DC/EEG recording (5a) reflects the depolarization 
of the neuronal elements as well. [Erwin-Josef Speckmann and Christian E. Elger, “Introduction to the 
Neurophysiological Basis of the EEG and DC Potentials” in Ernst Niedermeyer and Fernando Lopes da 
Silva (Eds.) , Electroencephalography: Basic principles, Clinical Applications, and Related Fields, p. 20, 
4th Ed., Williams & Wilkins, Baltimore 1999.] 
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According to Caspers [44], the cortical DC potential shift is an indicator of the cortical 
excitability changes with a negative shift showing an increased cortical excitability and 
a positive shift showing a decreased one. At the neuronal level, these potentials are 
proposed to reflect changes in the depolarization of apical dendrites and regulate local 
thresholds of excitability in cortical cell assemblies [29], [42]-[44]. The amplitude of 
SCP is reported to range from several µV (i.e., during a cognitive task) to more than 
100 µV during seizures [29]. 
In [28], different negative polarizations observed in different experimental settings are 
considered as the members of a family having different labels: “orienting wave”, 
“processing negativity”, “Bereitschaftspotential” in preparation for voluntary 
movements, and CNV if it occurs between two consecutive stimuli or responses. The 
neuroanatomical sources of SCP are claimed to depend on the stimulus modality and 
the type of information processing or motor responses involved. Local synchronous 
depolarization of the apical dendrites reflected in negative SCP is reported to increase 
the firing probability, whereas positive SCP disfacilitate the respective cell assembly in 
those instances in which no actual processing of stimuli or responses occurs [42]. 
Therefore, SCP are ascribed an active role in the preparatory distribution of sensory, 
motor, and attentional resources into the respective cortical areas [29]. It is shown that 
the response organization, perceptual processing, and problem solving accuracy are 
increased when the tasks are presented during negative SCP [29], [42]. Both in patients 
and in some animal experiments, high amplitude negative SCP shifts (e.g., over 100 µV) 
are observed shortly before and during seizures, as well as during epileptic patterns in 
EEG [44].   
Based on the view of an active modulatory role of the topographically specific SCP in 
cortical processing, it was hypothesized that patients with intractable epilepsy are 
characterized by an impaired ability to regulate their level of cortical activation using 
cortico-thalamic feedback loops. Thus, it is suggested that epilepsy patients can 
acquire the lacking cortical self-regulation during a process of learning based on the 
biofeedback of the SCP [45]. In several studies [25]-[27], [45], [46] it is reported that 
using this method, most patients with drug-resistant epilepsy could learn to control 
their SCP, resulting in a significant decrement in the seizure rate. Results of 1.5-year 
follow up studies have demonstrated a 50% average reduction of seizures, with some 
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patients being seizure free and some unchanged [23], [25]. A further study to predict 
the outcome of SCP based neurotherapy [47] reports that patients who have extreme 
negative SCP values before training respond less favorably. 
2.4 DC-Potentials in the Brain 
As mentioned in section 2.3.2, the DC-potentials are studied in various contexts under 
different provocations and paradigms. Behavioral changes associated with the sleep-
wake cycle, seizure activity, and deviations of gas pressures in blood and tissue serve as 
experimental models for investigating the DC-potentials in the brain. 
The following subsection presents an overview of different states of the brain, in which 
DC-shifts are observed, in order to have a more detailed insight of their role in brain 
functioning: 
2.4.1 Cortical DC-Shifts and Seizure Activity 
In experiments with cats, a negative cortical DC potential shift was found to be 
associated with a depolarization of the cortical neurons during tonic-clonic convulsive 
seizures. Although the changes of the fast DC-transients (i.e., EEG spikes) were 
observed to be more complex in the course of a generalized seizure activity, the shape 
and the polarity of the spikes have also been found to depend on the amplitude of 
sustained negative DC shift [48], [49].  
Many investigations have confirmed that seizure activity (both in focal and generalized 
convulsive discharges) in the cerebral cortex is associated with distinct deviations of 
the DC baseline in the negative direction with respect to the reference level, which is 
determined in the pre-ictal phase. Caspers [44] states: 
“With focal seizure activity elicited by topical application of a convulsant agent or by 
direct electrical stimulation, the negative DC shift exhibits maximum amplitude in the 
center of the focus and declines toward peripheral regions. Beyond a zone of complete 
extinction the evoked DC shifts often reverse in sign. Generalized convulsive 
discharges evoked, for example, by systemic application of convulsant agents are 
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usually preceded by a stage of increasing seizure susceptibility. As a rule, this phase is 
marked by slowly rising negative shift of the DC baseline all over the cortex.”  
Caspers [44] concludes that the negative DC shifts associated with seizure activity 
originate from a mixed generator of neurons and are functionally related to glial cells, 
and that the contribution of each of these elements to the compound response may vary 
in different brain regions depending on factors such as the relative density of the 
generator structures and the actual rise of the local K+ concentration. 
2.4.2 Cortical DC-Shifts and Gas Pressures in Blood and Tissue 
The DC-potentials are studied in association with the alterations of partial gas 
pressures, both pCO2 and pO2, in blood and tissue [44]. DC displacements are reported 
to result from a rise in the inspiratory CO2 contents as well as from a reduction of the 
ventilation rate (apnoea) or from a respiratory arrest following a period of breathing 
pure oxygen (oxygenated apnoea). The amplitude of the DC-shifts increases 
logarithmically with the rise of pCO2 and linearly with the fall in pH. A number of 
studies have been devoted to the origin and electrogenesis of the DC-shifts elicited by 
changes in pCO2 and/or pH. Besides neurons, glial cells and blood brain barrier have 
been taken into account as generator structures [44]. 
2.4.3 Cortical DC-Shifts and Cognitive Information Processing  
Cognitive information processing is another field of investigation related to cortical 
DC-shifts. Birbaumer [28] defines the SCP (e.g., CNV, Bereitschaftspotential, 
negativation during memory search) observed by using different paradigms as members 
of a family. 
Contingent negative variation (CNV) 
The CNV, which is observed in a paradigm where a warning signal precedes an 
imperative stimulus for a motoric activity, is shown to be related to the expectation and 
anticipatory attention, and claimed to be observable in all situations of subjective 
mobilization and anticipatory attention even without any motoric activity [28]. 
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Bereitschaftspotential (BP) 
Before a planned movement, a negativation occurs in the supplementary motoric 
cortex, which is shortly before the execution of the movement overlapped with a 
negativation at the contra lateral primary motoric cortex. The amplitude of BP is 
reported to depend on many psychological and kinematic characteristics, of which the 
automation level of the movement plays a primary role. The more the movement 
exercised, the lower the amplitude [50], [51]. 
Negative DC-shift during memory search  
In circumstances demanding memory search due to their complexity, a negative DC 
shift of 400 ms (or longer) occurs after the stimulus processing, which returns to the 
reference level after the solution of the task [52]. 
SCP associated with postural adjustment 
Saitou et al. [53] have investigated the existence of a cortical potential, similar to the 
BP, preceding postural adjustment followed by voluntary ballistic rising on tiptoe in 
healthy subjects. The slopes of the slow negative potential associated with the pre-
motion silent period onset were significantly more negative than those of the potential 
associated with rise-on-tiptoe movement, particularly over the frontal electrode 
positions. They conclude that the results suggest that a cortical potential precedes 
postural adjustment, which is followed by voluntary rising on tiptoe. 
2.4.4 Cortical DC-Shifts and the Sleep-Wake Cycle 
In animal experiments, the well-known changes in EEG waves during sleep-wake cycle 
are shown to be accompanied by distinct DC-shifts on the cerebral cortex too [44]. It is 
reported that at the transition from wakefulness to sleep, the baseline of the DC 
recordings usually shifts to the positive side of the reference level determined in the 
awake but relaxed animal. Furthermore, in most cortical regions, the amplitude of the 
DC-shift increases with the progressive slowing of the transients in the EEG frequency 
range [44].  
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2.4.5 Cortical DC-Shifts Associated with Anesthesia and Related Burst 
Suppression 
Yli-Hnakala et al. [54] demonstrated that the instantaneous heart rate (IHR) decreases 
during EEG suppression in deep enflurane anesthesia. Combining their results with 
two other observations, (1) burst suppression pattern in EEG occurs after ischemic 
brain damage [55] and during enflurane, isoflurane or barbiturate anesthesia [56], and 
(2) under enflurane anesthesia, hyperventilation provokes epileptic discharges during 
burst suppression pattern [57], Jäntti and Yli-Hankala [58] hypothesized that a non-
linear inhibiting mechanism exists in the CNS which inhibits the burst activity in both 
EEG and heart rate. They concluded that there is a control system in the CNS which 
synchronously inhibits EEG burst activity and heart rate. They presented the 
hypothesis that this inhibitory mechanism is related to the mechanisms that inhibit or 
limit epileptiform discharges. In their study in 1993, they combined their observations 
on burst suppression and IHR with the cortical DC potential shifts. They expanded 
their hypothesis and proposed that a non-linear (on-off) control system exists, which 
controls both the bursting and DC-shifts, as well as IHR [59]. 
 
3 Problem Analysis: Objective (Neuro)therapy 
Planning and Evaluation in Epilepsy 
Neurotherapy is introduced as a complementary treatment in various disorders of the 
CNS such as epilepsy, attention deficit hyperactivity disorder, depression, and chronic 
fatigue syndrome. The method is subsumed under behavioral medicine, and is 
considered an operant conditioning in terms of psychology. Although the application 
areas of this promising unconventional approach are rapidly increasing, the 
physiological underpinnings of the process are not yet well understood. Due to the lack 
of controlled studies for its evaluation, the approach is strongly debated: There is 
consensus neither on the applicability of double blind studies in this behavioral 
approach nor on its possible placebo effects. Especially in the case of epilepsy, which is 
also, as a complex disorder, not well-explained at the biochemical and physiological 
levels, the success of the treatment is even more debated. Therefore, verification of the 
efficacy of the treatment is one of the core issues in this field of research.  
Another issue of discussion is the individual diversity which has to be considered in 
neurotherapy: current investigations indicate that if the treatment is not individually 
adapted according to patient specific characteristics, the expected efficacy is not 
achieved [8], [24]. Neurotherapy needs to be planned and monitored subject 
specifically. 
Both of these issues, individualization of neurotherapy and verification/validation of the 
treatment, can be addressed under the heading of objectivity in diagnostics and therapy 
evaluation.  The very basic questions underlying the problem are:  
a. What is the specific pathology in a certain case, so that the therapy can be 
planned accordingly?  
b. What is altered in the brain through (neuro)therapy ?  
These questions, of their very nature, pertain to both neurology and psychology, and are 
related to the rationale of neurotherapy at both levels. Both of them can be handled via 
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determination and comparison of quantitative parameters reflecting the basic 
neurological functions, so that the therapy can be accordingly planned and evaluated. 
Thus, two further questions arise:  
c. How can we determine the pathology, or respectively, the changes in a certain 
case?  
d. How can we quantify them for an objective diagnostics, therapy planning, and 
evaluation?  
These latter two questions add the first engineering component to the problem as they 
are mainly related to data acquisition and signal processing.  
Another very important aspect of the problem orientation is the clinical practice. The 
practical aspects of clinical use and applicability must be considered in the solution. 
The iterative process of therapy evaluation which accompanies any treatment in 
medical practice can be summarized in a flow diagram Fig. 3.1.  
 
Examinations / Measurements
Therapy Planning / Modification
Therapy
Diagnostic / Therapy 
Evaluation
Termination
 
Fig. 3.1 General therapy evaluation flow diagram 
At the first step, diagnostic measurements and examinations are carried out. Based on 
the evaluation of the diagnostic results, the medical expert plans and then applies the 
therapy. After a certain period of treatment, the examinations (i.e., evaluation 
measurements) are repeated. Upon a therapy evaluation process, the therapy is either 
3  Problem Analysis: Objective (Neuro)therapy Planning and Evaluation in Epilepsy 21 
continued, respectively modified, by the medical expertise, or terminated if success is 
achieved (i.e, certain measures are normalized and clinical symptoms are overcome).  
As implicitly expressed in the above description, the therapy planning and evaluation 
procedures in medical practice is a more subjective process which highly depends on 
the expertise of clinical personnel. Despite the necessity, objectivity is achieved neither 
in neurotherapy nor in other therapies (e.g., pharmacological, surgical, etc.) applied in 
many neurological diseases. This is highly related to the lack of quantitative measures 
which can bring more objectivity to both procedures. The determination of generally 
applicable quantitative measures, however, has not been achieved, due to the diversity 
of cases and variety of the treatment modalities in epilepsy as in many other 
neurological disorders. Additionally, the diversity yields an excessive amount of 
information to be managed and processed in both diagnostics and therapy evaluation. 
The desired solution to the problem of objectivity shall be applicable (with some 
modifications or supplements) to neurological disorders in the realm of the 
neurotherapy, though our focus shall be on epilepsy as a specific disorder. This aspect 
adds the second engineering component to the problem: development of a strategy 
which can be implemented in terms of information technology for a possible 
automation of the process. Hence the problem considered is an interdisciplinary one, 
having neurology, psychology and biomedical engineering (in terms of data acquisition, 
signal processing and data management) as its components (Fig. 3.2). 
Having elucidated the fundamental problem orientation, for a possible solution, we 
need to advance to a more detailed analysis of procedures followed in therapy 
evaluation in epilepsy. 
Traditionally, pharmacotherapy is the first treatment addressed in epilepsy. It begins 
with monotherapy in which the patient is prescribed a single substance. According to 
the outcome of the therapy, the substance is either replaced by another one or 
supplemented with further substances (i.e., co-medication). The sort and doses of the 
substance is decided according to the seizure frequency and intensity as well as the 
side-effects [11], [61]. Despite the further development of highly effective antiepileptic 
substances, a significant percentage (i.e., 25%) of epilepsy patients is still pharmaco-
resistant [60]. 
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Fig. 3.2  Components of the problem analysis and orientation. 
As explained in section 2.2, the main target of epilepsy treatment is preventing, or at 
least, reducing the seizures. Therefore, the main criteria in the clinical evaluation of 
epilepsy are the frequency and intensity of the seizures which are registered on a 
seizure calendar kept by the patients.  
The conventional clinical follow-up of pharmacological epilepsy therapy is based on 
three main tools [61]: 
a. the seizure calendar which documents the type, the number and the intensity of 
the seizures, 
b. the data on the pharmacotherapy (sort of medicine prescribed, the time span of 
prescription), and 
c. the blood serum level of the active substance acquired in time intervals. 
Based on this information, the course of the treatment can be graphically 
represented [61]. The change in frequency and/or intensity of seizures is an important 
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quantitative clinical parameter for therapy evaluation. Nevertheless, the evolution of 
epilepsy, with or without treatment, can be vicissitudinous in most cases. A 
spontaneous improvement can be misinterpreted, especially if a sufficiently long time-
span is not considered [61].   
The seizure calendar is an invaluable tool for clinical evaluation. There are additional 
clinical examination results which are considered in diagnostics and therapy evaluation 
by the medical expert. These include the verbally expressed information such as the 
anamnesis, family history for genetic relevance, the impressions of the doctor, and 
clinical reaction tests on the general neurological and psychological state of the patient. 
The difficulty of using this information is the quantification, since they are purely 
verbal. This issue can be addressed by a knowledge-based system approach in terms of 
information systems. Nevertheless, none of these information components reflect any 
objective psycho- or neuro-physiological correlates of the efficacy of any treatment and 
cannot answer the question of placebo effects.  
Therefore, other tools which can yield objective parameters are needed. The possible 
parameters of biochemical level (i.e., alterations in neurotrasmitters or in membrane 
mechanisms) have to be excluded, since the corresponding in vivo data acquisition (i.e., 
measurements at the neuronal level) is not possible for clinical use.  The in vitro tools 
can be methods such as electroencephalogram (EEG), magnetoencephalogram (MEG); 
and imaging techniques such as computed tomography (CT), single photon emission 
computed tomography (SPECT) and positron emission tomography (PET), and 
functional magnetic resonance imaging (fMRI).  
Among these methods, the EEG is the one which is more established in clinical use, not 
only in epilepsy but also in other neurological and/or psychological disorders because of 
its relative simplicity and lower costs compared to other methods of neurological 
diagnostics. Although the spatial resolution of the clinically practiced 10/20 system 
EEG measurements cannot compete with of the other methods, the time resolution is 
superior, and thus can yield essential information on the cerebral functions or 
respectively, dysfunctions.   
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3.1 EEG in Epilepsy 
The EEG examinations in epilepsy are employed, basically in order to observe the so 
called epileptic graphoelements which may occur in interictal (i.e., the intervals 
between seizures) periods. The epileptic graphoelements are characterized by short 
lasting EEG abnormalities such as high amplitude spikes or sharp-waves, spike wave 
complexes, slow spike wave complexes, and polyspikes [62]. The time characteristics 
as well as the topography of such graphoelements are considered in epilepsy for 
diagnosis. The ictal charges (i.e., recorded during a seizure) which vary more, but 
usually consist of abnormally rhythmic EEG patterns are also important for epilepsy 
diagnosis. In some rare cases, there might also be alterations (e.g., slowing), which are 
often unspecific, in EEG background activity. Such alterations in background EEG 
activity can also be due to medication [62].  
The standard EEG measurement in clinical practice lasts commonly between 20-30 
minutes. This duration is often insufficient for detecting epileptic graphoelements or a 
seizure. Additionally, the existence of epileptiform discharges does not always mean 
existence of a seizure in clinical terms. Therefore, long-term EEG monitoring (over 24 
hours), either ambulatory or combined with video monitoring if the patients are           
in-patient, is emphasized as an important tool in diagnosis and differential diagnosis of 
epilepsy [63].  
Activation Methods 
Several activation methods, such as hyperventilation, photostimulation, and sleep 
deprivation are also commonly used in clinical routine in order to provoke epileptic 
discharges and other diagnostically relevant alterations in EEG [64].  
Although all these methods are important tools, the resulting EEG data are in general 
visually analyzed and evaluated. Therefore, the evaluation depends strongly on the 
clinical expertise, hence it is subjective. 
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3.2 Quantitative EEG in Epilepsy 
In order to overcome the problem of subjectivity, relevant EEG measures need to be 
quantified. With the developments in computer technology and digital time-series 
analysis, numerous mathematical and statistical methods are also applied in EEG 
analysis. These include a wide spectrum of methods from the established spectral 
analysis to more recent methods of non-linear analysis such as fractal dimension, 
Lyapunov exponents, and wavelets. The relevance of these parameters to certain 
pathologies, as in epilepsy, however, is incomplete in the literature.  
Although all the methods mentioned above are means of EEG quantification, the qEEG, 
as a term in the realm of objective and automatic neurological and psychiatric 
diagnostics and therapy evaluation (i.e., neurometrics [5]), defines a certain set of 
measures, which are extracted from EEG data at a standardized state (i.e., 2 minutes of 
artefact free eyes closed alert resting state EEG) [6]-[8]. These measures include [6]:  
a. absolute and relative spectral power in the traditionally accepted EEG 
frequency bands (delta (1.5-3.5 Hz), theta (3.5-7.5 Hz), alpha (7.5-12.5 Hz, beta 
(12.5-20.5 Hz)),   
b. mean frequency in these bands, 
c. mean coherence between homologous electrode pairs of hemispheres, 
d. inter- and intrahemispheric symmetry (or asymmetry) of the absolute power of 
the frequency bands between homologous electrodes.    
On the other hand, the neurometrics [5], as the methodology of analysing these 
measures defines the whole procedure of:  
a. fast Fourier transformation (FFT),  
b. calculation of the quantitative parameters,  
c. logarithmic transformation of these measures to obtain Gaussianity,  
d. age-regression,  
e. Z-transformation relative to population norms,  
f. topological presentation of the results via mapping, and 
g. multiple stepwise discriminant analysis for clustering according to disorders.  
In spite of the fact that qEEG and neurometrics offer a possible solution in many 
neurological and/or psychiatric disorders (e.g, schizophrenia, major affective disorder, 
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alcoholism, dementia and learning disabilities [5], [8]), distinguishing them from 
healthy controls as well as from each other, this is not the case in epilepsy. This is not 
only because these measures often do not deviate from the norms in epilepsy, but also 
because the deviations cannot be clustered due to the high diversity.  
There have been some approaches for possible objective therapy evaluation in 
SMR-based neurotherapy studies in epilepsy. The earlier study focuses on the 
normalization of sleep EEG (i.e, reoccurrence of sleep spindles, which were absent 
before EEG-biofeedback in some patients) after neurotherapy [65]. The recent studies 
take the so called comodulation (as coined by Sterman and Kaiser [66]) as the metric of 
quantification. The parameter is described to examine the temporal correspondence of 
magnitude modulation between cortical recording sites, and is applied as a cross-
correlation analysis either within the subject, or statistically between subject and a 
control database. The mathematical formulation of the metric, however, is not 
explicitly defined in the literature.   
3.3 Objectives 
Based on the analysis in the previous sections of the current chapter and the basics 
introduced in chapter 2, we can now continue with our strategy for a possible solution: 
Primarily, it is necessary to search further quantifiable information from the EEG and 
possibly from evoked potentials and/or event related potentials which might also 
reflect dysfunctions related to epilepsy. These measures should correspond to the 
following aspects: 
a. Because of their relevance to clinical practice, they should correspond to 
i. the possible graphoelements in standard or long-term EEG, and 
ii. the reaction to activation methods used in epilepsy diagnostics,  
b. Because of their relevance to neurotherapy protocols proposed in epilepsy, they 
should correspond to 
i. possible alterations  in the evoked and/or event related potentials, and 
ii. possible alterations in the slow cortical potentials.       
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Although automatic detection, quantification and statistical analysis of graphoelements 
for diagnostics and therapy evaluation has been studied to some extent, the other 
parameters have not been considered for the purposes of objective diagnostics, 
(neuro)therapy planning and evaluation. This is highly related to the gap between basic 
research and the clinical practice in neurology and psychology, as well as the fact that 
epilepsy is a complex disorder which is not well explained at either the biochemical or 
the physiological level. Thus, at this point, we come back to the fact that our problem 
has roots in basic research in neurology and psychology (Fig. 3.2). 
For the solution of the problem, a therapy evaluation strategy with a data acquisition 
protocol including the necessary measurements for these further parameters needs to 
be developed. The protocol should also be clinically applicable. The measurements 
included in the protocol shall be taken from patients and healthy controls. 
Corresponding signal processing algorithms are to be chosen and applied to the 
acquired data. Since the analysis of all the parameters is far beyond the scope of the 
current study, selected parameters shall be compared between patients and controls 
according to their relevance to the rationale of neurotherapy. For a possible automation 
of the process, the procedures should be integrated in a software concept, which also 
considers structuring and management issues of the excessive amount of data and 
clinical information gathered.      
In terms of biomedical engineering, the solution can be subdivided into the following 
major parts:  
a. Development of a strategy for objective diagnosis, (neuro)therapy planning, and 
evaluation 
b. Data acquisition corresponding to the strategy 
i. A protocol for the pre- and post- therapy measurements necessary for 
further measures 
ii. Measurements from healthy controls and patients 
iii. Realization of neurotherapy on patients 
iv. Repetition of the protocol after the therapy 
c. Signal processing 
i. Analysis of selected parameters 
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ii. Extraction of possible quantitative features 
iii. Comparisons between healthy controls and patients 
iv. Pre- and post-therapy comparisons 
d. Data management 
i. A software concept which can cover the components for signal 
processing and management of the extracted parameters, so that an 
automation of the procedures can be achieved 
 
4 Therapy Evaluation and the Neuroprofile 
In this chapter, the developed therapy evaluation strategy with the concept of 
neuroprofile will be introduced. Associated with this strategy, the protocol for initial 
and evaluation measurements will be presented. 
4.1 The Therapy Evaluation Strategy 
As discussed in chapter 3, one of the main components of the solution to the problem of 
an objective diagnosis and (neuro)therapy evaluation, is a strategy which can 
standardize the process. Hence, in this section, a therapy evaluation strategy based on a 
new concept and tool, the neuroprofile, will be introduced.   
The information processed in therapy evaluation in epilepsy can be roughly divided 
into two categories:  
a. the signal analytically quantifiable, purely numeric measures which can be 
extracted from EEG and possibly from other bioelectrical signals, and 
b. the verbal medical information which includes the clinical examination results 
as expressed by the expertise.  
More objectivity can be attained via a strategy based on the first category of 
information. The second category of information, however, should also be accessible.  
4.1.1 The Neuroprofile  
The term neuroprofile is coined in order to define a structured set of possible quantifiable 
measures which can be extracted from electrophysiological signals and characterize the 
neurological functions of a subject. The neuroprofile, as a clinical tool, is 
conceptualized as a three dimensional vector having the dimensions: 
a. Quantitative measure, 
b. Localisation (e.g., electrode position), and 
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c. Time. 
The dimension time involves the smaller intervals within the measurements having 
different provocations, as well as the successive measurements. The dimension 
localisation projects the electrode positions of EEG recordings according to the 
international 10/20 system, or of other electrophysiological signals (e.g., ECG, 
electrooculogram (EOG)) according to the type of derivation. And finally, the 
quantitative measures dimension represents the parameters extracted from the signals 
after processing. Fig. 4.1 illustrates the model for the neuroprofile.  
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Fig. 4.1 Sample section from the qEEG part of the neuroprofile model. The highlighted column shows the 
parameters extracted from EEG (e.g., DC-level; delta, theta, alpha1, alpha2-frequency band powers; 
amplitude of mu rhythm) from a single time-interval of a single provocation for a given channel. © IEEE 
Transactions on Information Technology in Biomedicine. 
The neuroprofile is central in the developed strategy. The quantitative results of pre-
therapy, as well as follow-up measurements are registered in the neuroprofile for 
further statistical comparisons. The developed strategy can be illustrated in a flow 
diagram (Fig. 4.2). 
The process begins with initial measurements and consideration of already existing 
information (i.e., previous measurements and examination results) for a given case. In 
order to have a standard for later statistical comparisons, an extended protocol of 
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clinical EEG measurements including different provocations, and event related 
potentials (ERP) measurements relevant to epilepsy (i.e., initial and evaluation 
measurements) are carried out. 
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Fig. 4.2 Therapy evaluation flow diagram. Initial measurements, as well as evaluation measurements are 
analyzed by the data analysis module, which extracts the neuroprofile. Based on the neuroprofiles, 
therapy is evaluated and accordingly, is either continued unchanged or modified, or terminated. 
The protocol will be explained in detail in this chapter. The measurements are analyzed 
in order to extract different quantitative measures which compose the user specific 
information (i.e., data analysis). The quantitative results are then integrated into the 
neuroprofile. Based on the initial neuroprofile, a neurotherapy modality (i.e., the 
feedback parameter, the electrode position to be trained, the modalities of feedback and 
task definitions –visual, acoustic or combined) is proposed, and an initial supervised 
training is realized. The therapy is conducted if the supervising medical doctor 
approves the proposed modality. In the course of the therapy, the evaluation 
measurements protocol is repeated and the neuroprofile is updated. The neuroprofiles 
referring to a particular case are statistically compared (i.e., evaluation). Accordingly, 
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the therapy is continued or modified. The iterative process is repeated until clinical 
success is achieved. 
4.2 Protocol for Evaluation Measurements 
An extended protocol of clinical EEG measurements is proposed in this study in order 
to obtain standardization for the comparison of neuroprofiles. Clinical factors 
considered for the proposal include applicability, duration, priority of relevance to 
epilepsy and neurotherapy, and recent findings in basic research in neurology and 
psychology, which do not have clinical applications yet. The measurements included 
were determined through consultation with the medical partners. After some 
modifications, the final protocol is as follows (Table 4-1): 
The first part (standard I) of the protocol includes background EEG/DC acquisition in 
an open-eyes alert state as well as during essential clinical activations such as the 
Berger effect, hyperventilation and apnoea.  
The ERP measurements include three paradigms: Odd-ball paradigm for P300, S1-S2 for 
CNV and a motoric reaction paradigm for SMR measurements. Photo-stimulation is 
used for the final measurement (standard II). This activation method is separated from 
the first part because of the influences of light adaptation processes on the measured 
DC component [67].  
In order to gain a better insight for the protocol, the activation methods and the 
paradigms used will be explained below: 
Activation Methods 
a. Berger Effect 
This method refers to the alpha activity predominant in occipital region in an eyes-
closed alert state, which is suppressed when the eyes are open, as described by  
Hans Berger. This activation method is normally applied for 3-5 sec in order to 
examine the reactivity, which may be absent in some epilepsy cases, especially due 
to long term medication [62]. The eyes-closed and eyes open alert states are also 
essential for comparison of the two states. Additionally, for further signal analysis, 
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the eyes-closed alert state is more suitable, since the EEG is less contaminated with 
ocular artefacts. The duration of an eyes-closed alert state in the protocol is, 
therefore, longer (i.e., 5 min).  
b. Hyperventilation (HV) 
It is well-known that hyperventilation precipitates seizure activity in epilepsy 
patients. Therefore, it is commonly used as an EEG activation method in clinical 
routine examinations. The epileptic discharges induced by hyperventilation have a 
crucial diagnostic value. This method consists of deep and regular respiration at a 
rate of about 20cycles/min for a period of 2-4 minutes. In adults, such HV causes an 
air exchange of 20-50lt/min and a drop in pCO2 in the range of 4-7ml%. The 
characteristic EEG response to HV, most prominent in children, consists of 
fluctuating increase of bilaterally synchronous slow activity and the slowing of 
alpha and beta rhythms. In normal adults, although the slowing is generally not 
marked, there are wide differences among individuals. For the purpose of routine 
examination with HV, however, it is suggested that the rate of breathing be as close 
as possible to that of the resting rhythm (15-20 breaths/min) [68].  
Another effect of hyperventilation on the EEG is observed in the DC-shifts, 
especially at the vertex. These potentials, however, are not commonly studied, since 
the measurement requires more sophisticated equipment and is highly open to low 
frequency artefacts. They are addressed, though, for their relevance in the context of 
the SCP based neurotherapy in epilepsy [43], [60], but not studied for their possible 
diagnostic value. Therefore, this activation constitutes an essential part of the 
protocol. 
c. Apnoea 
An apnoeic episode is defined as a cessation of breathing of longer than a 10 sec 
duration. Although such episodes are mostly considered in sleep EEG studies (e.g., 
sleep disorders) and it is not a standard activation in epilepsy diagnosis, it is an 
important activation which needs to be investigated more in detail in the realm of 
basic neurology research within the realm of DC studies, as a counter reaction of 
hyperventilation.  
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Table 4-1 The protocol for evaluation meaurements. 
Measurement State Activation/Paradigm Activity Duration 
 
Standard I 
Eyes-open alert --- Background 
EEG/DC 
2 min 
 Eyes-closed 
alert 
Berger effect (reactivity) Background 
EEG/DC 
5 min 
 Eyes-open alert --- Background 
EEG/DC 
2 min 
 Eyes-open alert Hyperventilation (HV) EEG/DC 3 min 
 Eyes-open alert Recovery from  HV EEG/DC 3 min 
 Eyes-open alert Apnoea EEG/DC 20 sec 
 Eyes-open alert Recovery from apnoea EEG/DC 3 min 
 Eyes-closed 
alert 
Berger effect (reactivity) EEG/DC 2 min 
 Eyes-open alert --- EEG/DC 2 min 
ERP 1 Eyes-open alert Odd-ball P300 200 trials 
 Eyes-closed 
alert 
Odd-ball P300 200 trials 
ERP 2 Eyes-open alert S1-S2 CNV 44 trials 
ERP 3 Eyes-open alert Motoric reaction SMR 100 trials 
 
 
Standard II 
 
Eyes-closed 
alert 
Photo-stimulation 
Ramp (1-30 Hz): 
1, 3, 6, 9, 12, 15, 18, 21, 
24, 27, 30 Hz and 
backwards. 
 
Photosensibility 
8 sec stimulation, 
8 sec pause at the 
listed frequencies. 
d. Photo-stimulation (PS) 
Photo-stimulation is especially important for the evaluation of photosensitivity, 
which is encountered in certain seizure types. The paroxysmal discharges related to 
PS are crucial for diagnosis. Details of PS use in routine examination vary highly 
between EEG labs. According to [69], the following protocol is suggested by 
Bickford [70]: flashes at frequencies of 1, 3, 6, 9, 12, 15, 18, 21, 24, 27, and 30 Hz each 
are given for a duration of 5 seconds with eyes open and closed in a room with 
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reduced illumination. The PS is integrated into the protocol with the above listed 
frequencies only when the eyes are closed, with 8 seconds stimulation, 8 seconds 
pause intervals. The intervals are assigned longer, so as to facilitate the signal 
analysis afterwards. 
Paradigms 
a. Odd-ball 
Selective and sustained attention and short term memory deficits have been 
reported in epilepsy. P300 as a measure of attentional resource and as a measure of 
cognitive functions is discussed in the context of epilepsy diagnosis, and differences 
are reported in the latency and amplitude of P300 in epilepsy [71]-[73]. These 
findings, however, are not integrated to the clinical practice yet. Therefore, an 
auditory odd-ball paradigm is included in the protocol. Standard tones of 1000 Hz 
(100 ms duration) are presented once every 2 sec with a 2000 Hz target tone 
occurring randomly in 20% of the trials. Subjects are requested to press a button 
with the thumb of their right hand as quickly and accurately as possible when the 
target tone is perceived. The eyes closed and eyes open options are necessary for a 
possible comparison of the two states.  
 Ss Ss
t t t
t
t
Ss Ss SsSt
Response  
Fig. 4.3 Odd-ball paradigm. Ss = standard tone of 1000 Hz (duration 100 ms); St = target tone of 2000 Hz 
(duration 100 ms, occurrence 20%); t = 2 sec.   
b. S1-S2 
The CNV is a long-latency event-related potential elicited by paired or associated 
stimuli. The slow negativity in the EEG appears during the anticipation period 
between a warning stimulus (S1) and a target response “imperative” stimulus. Its 
neural generators are hypothesized to be at the prefrontal cortex. This activity is 
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considered one of the possible negative polarizations, an example of which is 
Bereitschaftspotential. CNV is addressed in the context of SCP based neurotherapy. 
According to [28], CNV is observable in all situations of subjective mobilization 
and anticipatory attention regardless of  motoric activity.  
Hence, a modified S1-S2 paradigm without motoric activity is integrated into the 
protocol: An acoustic stimulus (S1) preceding a visual aversive or non-aversive one 
(S2) is presented. The S1 (i.e., two distinguished tones) warns whether the S2 is 
aversive or non-aversive. And accordingly, the S2 is a randomly assigned aversive or 
non-aversive picture from the International Affective Picture System (IAPS)7. For 
the standardization of the measurements, the inter stimulus intervals are assigned 
as t1=6 sec, t2=6 sec, and t3=4 sec (Fig. 4.4).  
 
t1 t2 t3
Warning
S1
Aversive or 
non-aversive
S2
Pause
 
Fig. 4.4 Modified S1-S2 paradigm. S1 = acoustic warning stimulus, S2 = visual aversive or non–aversive 
stimulus. t1 = 6 sec, t2 = 6 sec, and t3 = 4 sec. 
c. Motoric reaction (SMR) 
The SMR activity, which forms the basis of one of the main neurotherapy protocols 
in epilepsy, is included because of its relevance to neurotherapy (see. chapter 2 
section 2.3.1). 
An SMR paradigm is constructed for the protocol where the subject is requested to 
respond according to the presented imperative visual stimulus by pressing two 
different buttons either with the left hand thumb or the right hand thumb, or by 
show no reaction (Fig. 4.5). 
                                                         
7 International Affective Picture System (IAPS) is a development of the Center for the Study of Emotion 
and Attention (CSEA) directed by P. J. Lang at the University of Florida. 
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SoSrSl Sr Sl
t
So
Rr Rr Rl  
Fig. 4.5 Paradigm for SMR measurements. Sl = visual stimulus for left hand thumb response Rl, Sr = visual 
stimulus for right hand thumb response Rr, So = visual stimulus for no-reaction. t = 3 sec. 
There are certainly other possible measurements which can be included in the protocol. 
Nevertheless, the solution considers to optimize the over-all measurement duration and 
the priority of the relevance to epilepsy and neurotherapy. The durations of single 
measurements are assigned according to the necessities of further signal processing.  
Although not all the measurements included in the protocol can be analyzed within the 
scope of this work, the protocol is extensively structured so as to provide vital 
information embedded in the initial measurements, which cannot be replicated after 
the therapy. The signal analysis (quantification) will only consider selected 
measurements.  
 
5 Data Acquisition 
The current chapter is devoted to the measurements and the acquired data. After a brief 
introduction of the EEG-biofeedback system, the technical settings of different 
measurement types, as well as the details of the acquired electrophysiological signals 
are presented. The focus shall then be on the laboratory studies with voluntary control 
subjects and clinical applications with epilepsy patients. 
5.1 The EEG-Biofeedback System 
The original system used for data acquisition in this study was a 32- channel AC/DC 
polygraphic amplifier system [74]. Using certain modalities of the original one, a 
laboratory prototype for an adaptive BCI system, which can be also utilized for EEG-
biofeedback and neurotherapy applications, was developed by the NeuroCybernetics 
Research Group [1], at the Technische Universität Ilmenau, Institute of Biomedical 
Engineering and Informatics.  
The system is conceptualized in the form of two units; one central and one portable. It 
can be configured for different disorders and adapted according to the individual needs 
and characteristics of the subject for flexible EEG-biofeedback [2]. The central unit 
involves modules for selecting an individual specific training protocol and configuring 
the corresponding necessary software components [4]. After determining the 
configuration for a certain subject, the initial familiarization stage of EEG-biofeedback 
can be realized with the central unit under the supervision of a medical professional. 
Upon completion of the first stage, the training process can be continued either at the 
central unit or, after the transfer of the subject-specific configuration to the portable 
unit, on the portable one (i.e., home-training) [3]. A simplified block diagram of the 
central unit is illustrated in Fig. 5.1. 
The AC/DC amplifier system acquires EEG signals, which are monitored by a software 
component. The control/monitoring software also assigns the feedback parameter(s) 
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and the sequences of stimulation/task-definitions. Based on the assigned feedback 
parameter, a control time-series is extracted by a separate on-line signal processing 
software module. The multimedia animation is then controlled by the extracted time-
series. During the session, an additional software component continuously updates the 
results. After the sessions, it presents over-all averages.  
SUBJECT
Control / 
Monitoring
Signal 
Acquisition
Online Signal 
Processing
Stimulation / 
Task Definition
Result
Presentation
Multimedia 
Feedback
 
Fig. 5.1 Simplified block diagram of the developed EEG-biofeedback system. EEG/DC signals are acquired by 
the signal acquisition module, which is controlled and monitored by a separate software module. The 
signals are processed on-line, and the multimedia feedback is controlled by the extracted feedback 
parameter. 
Three distinguishing features of the system can be listed as follows:  
a. Not only higher frequency components, but also very slow components 
(including 0 Hz) can be acquired.  
b. Besides EEG, other polygraphic signals such as electrocardiogram (ECG), 
vertical and horizontal electrooculograms (VEOG and HEOG), and respiration 
curves (ATHM) can be simultaneously acquired.  
c. Multimedia feedback components can be configured according to the needs of 
the subject. 
Some modalities of the system are illustrated in Fig. 5.2 and Fig. 5.3. More details about 
the developed system can be found elsewhere [2]-[4]. 
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(a)              (b) 
Fig. 5.2 Modalities of the system. (a) Evaluation measurement using LCD glasses (28 channels EEG), 
(b) Biofeedback session (single channel EEG). © The NeuroCybernetics Research Group.  
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(b) 
Fig. 5.3 Samples of the multimedia feedback components. (a) Airplane: amplitude controlled feedback, 
(b) Puzzle: band power controlled feedback. © The NeuroCybernetics Research Group. 
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The measurements obtained through the study can be roughly grouped into two types:  
a. evaluation measurements, and  
b. EEG-biofeedback sessions.  
These will be addressed in the following sections: 
5.2 Evaluation Measurements 
Both the initial diagnostic measurements and the therapy evaluation measurements are 
grouped under this category. These measurements mainly involve the application of the 
protocol proposed in section 4.2. The acquired polygraphic data consist of:  
a. 28 unipolar EEG channels according to the International 10/20 System 
(reference: linked mastoids) (see Fig. 5.4 for electrode positions),  
b. an ECG channel according to Einthoven I derivation (right and left arm), 
c. a bipolar VEOG channel, 
d. a bipolar HEOG channel, and 
e. a bipolar respiration channel (via respiration belt). 
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Fig. 5.4 The 28 channels of EEG acquired in an evaluation measurement (10/20 System). 
A sampling rate of 500 Hz is assigned to all channels for a higher frequency resolution. 
The DC modus is used (no high pass filtering) for the EEG channels, where the low 
pass filter (i.e., high cut-off) is set to 70 Hz. For all measurements, the electrode 
impedances are guaranteed to be less than 2 kΩ. A sample interval of the signals 
acquired during an evaluation measurement is shown in Fig. 5.5. The room conditions 
(i.e., light and temperature) are kept constant during a measurement. In order to avoid 
the influences of the highly discussed “time of the day” factor in EEG measurements, 
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the evaluation measurements referring to a particular subject are started at the same 
hour of the day each time the measurements are taken. 
 
Fig. 5.5 An interval from the polygraphic signals acquired during an evaluation measurement. 
5.3 EEG-Biofeedback Sessions 
According to our experience, the long-term process of EEG-biofeedback can be divided 
into the following stages: 
a. familiarization: getting familiar with the procedure, 
b. training: gaining the skill,  and improving it (i.e., achieving a higher success rate 
in trials),  
c. transfer: training without feedback for transferring the skills to daily 
conditions, and 
d. refreshment: maintenance of the skills gained after longer breaks. 
The first two stages, (a) and (b), together can be considered as “the process of learning”. 
The third stage (c) is essential for the patients to apply the learned skills in day to day 
situations, in which no feedback can be supplied. The last stage is important for the 
long-term follow-up in order to sustain the skills gained. The term “EEG-biofeedback 
sessions” refers to the sessions at all four stages, otherwise explicitly stated in the text.  
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In our studies, the sessions were based on self-regulation of the central or frontocentral 
SP. Sessions were configured subject specifically: The feedback electrode was assigned 
according to the topology of the CNV, and the range of the feedback component 
according to the amplitude of the CNV, which were determined after the evaluation of 
the initial measurements. Different modalities (e.g., acoustic, visual or combined) of the 
multi-media feedback module of the BCI system were configured according to the 
needs and preferences of the subjects. The task was defined as controlling the selected 
multimedia feedback component in two opposite directions corresponding to positive 
and negative DC shifts according to the delivered random sequence of instructing 
stimuli. Subjects were given no further instructions.  
We define a session as an approximately 15 minutes of continuous feedback containing 
40±1 trials. Two successive trials in a session are separated with a break interval which 
randomly varies between 6 and 12 seconds in order to prevent habituation. All the 
parameters related to the task declaration can be configured subject-specifically too. A 
subject is expected to complete 4 to 6 sessions during an EEG-biofeedback 
measurement.  
In a session, the subject is expected to distinguish between two different states of 
activation at the selected electrode position. In SCP based EEG-biofeedback, these two 
states are defined as “negativation” and “positivation”. As the terms suggest, they refer 
to the shifts in the baseline (i.e., DC) either in the negative or positive direction with 
respect to a reference level. In our realization, the reference level is automatically 
initialized before each trial.   
A standard EEG-biofeedback session data-set is composed of: 
a. a single EEG channel (i.e., the feedback electrode), 
b. a bipolar VEOG, 
c. a bipolar HEOG, and 
d. an ECG channel. 
For standard sessions a sampling rate of 100 Hz is assigned to channels. The DC modus 
is used (no high pass filtering) for the EEG channel, where the low pass filter (i.e., high 
cut-off) is set to 30 Hz. In certain training sessions, the respiration channel is added to 
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the set-up. The feedback electrode impedances are assured to be less than 1 kΩ. In order 
to avoid the influence of light adaptation on the recorded DC shifts, which was 
observed in the course of the study, the illumination of the room is kept constant 
through a session. 
Besides standard sessions, several training sessions were carried out in addition to the 
evaluation measurements, where the acquisition set-up was kept the same as the 
evaluation measurements (section 5.1). The feedback electrode was assigned to the 
same position as the standard sessions, and signals of all 28 EEG channels were 
recorded. The acquired signals can be summarized in the diagram below (Fig. 5.6). 
 
Evaluation measurements
  a.  28 unipolar EEG channels
       (10/20 system),
  b.  Bipolar VEOG,
  c.  Bipolar HEOG,
  d.  ECG channel,
  e.  Respiration channel 
       (respiration belt.) 
Controls Patients
Polygraphic data
EEG-biofeedback sessions
  a.  Single EEG channel
       (i.e., feedback electrode),
  b.  Bipolar VEOG,
  c.  Bipolar HEOG,
  d.  ECG channel,
  e.  Additional respiration
       channel when necessary.
 
Fig. 5.6 Acquired signals in different measurements from controls and patients.  
5.4 Studies with Control Subjects 
A control group is studied within the realm of the current thesis. The primary purpose 
was to acquire data for comparison with the patients. The secondary purpose was to 
conduct EEG-biofeedback sessions in order to test the functions of the developed 
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system, as well as to observe possible influences of neurofeedback on healthy controls. 
The study was necessary to establish a basis for clinical applications. 
Six voluntary subjects (4 males, 2 females) participated in the studies at the 
Electrophysiological Laboratory of the Institute of Biomedical Engineering and 
Informatics, Technische Universität Ilmenau. The subjects were expected to take part 
in 6 EEG-biofeedback sessions per week until having completed at least 40 sessions in 
total, as well as the evaluation measurements. The schedules were determined 
according to the availability of the candidates.  
The proposed protocol of evaluation measurements was employed at the beginning for 
the initial evaluation. The feedback electrode is individually determined after the initial 
evaluations. The protocol is repeated after completing 21±3 sessions (i.e., evaluation 
measurement 2) and at the end of the study (i.e., evaluation measurement 3).  The 
resulting measurements are listed below in Table 5-1.  
Table 5-1 Measurements carried out with control subjects.  
Four subjects (2 males and 1 female) completed the required minimum number of 
sessions, as well as the evaluation measurements. A female subject (S2MN) missed 3 
sessions, whereas a male subject (S6CR) dropped out after 18 sessions because of 
private problems. 
Subject 
Code 
 
Sex 
(m=male, 
f=female) 
Age Evaluation 
Measurements 
 
Standard 
sessions 
Sessions 
with 28 
channels 
EEG 
Feedback 
Electrode 
Feedback 
Type 
Task 
Declaration 
   1 2 3 (#) (#)    
S1JN f 21 + + + 42 5 Fcz Visual Audio 
S2MN f 21 + + + 30 7 Fcz Visual Audio 
S3AD m 21 + + + 39 6 C3 Visual Audio 
S4OL m 26 + + + 36 6 Fcz, Cz Visual Audio 
S5PT m 21 + + + 45 7 Fz, Fcz Visual Audio 
S6CR m 24 + - - 18 - Fz Visual Audio 
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5.5 Studies with Epilepsy Patients 
The clinical applications were conducted under the supervision of medical partners, 
either at the Neurology Clinic of the Zentral Klinik Bad-Berka (supervision by Chefarzt 
Doz. Dr. med. habil. R. Both) or at the Electrophysiological Laboratory of the Institute 
of Biomedical Engineering and Informatics (supervision by Prof. Dr. med. D. Müller, 
Neurological Praxis Ilmenau). The patients are selected and assigned for neurotherapy 
by the medical partners. Therefore, various patients were evaluated and treated at 
different times throughout the study. The patients (n=6, 4 females, 2 males) were 
diagnosed with focal or multi-focal epilepsy with at least 15 years of intractable 
epilepsy history.  
The neurotherapy sessions had to be organized according to the availability of the 
patients. A different schedule had to be followed for the patients, due to the health 
insurance regulations: In the first two weeks of the therapy, which was in-patient and 
covered by the insurance, the patients were trained intensively (i.e., daily except 
Sundays with an average of 8 sessions per day). The training continued once a week 
(i.e., 6 to 8 sessions), until the learning was achieved. Learning was accepted to be 
achieved, if at least 70% of the trials in successive sessions were successful. After the 
learning stage was completed, transfer sessions were conducted. The follow-up 
continued with refreshment sessions once every three months for those patients who 
accepted to continue with the treatment ambulatory after the first two weeks. 
The evaluation measurements are obtained at the beginning of the therapy, after the 
completion of the first two weeks, and in the course of further training. The resulting 
measurements are listed in Table 5-2. 
For certain comparisons between the controls and patients, for which no neurotherapy 
is required (e.g., CNV amplitude and topology), additional data from previous studies 
have been integrated into the analysis. The additional data includes measurements from 
other controls (n=5) and epilepsy patients (n=6) with focal or multi-focal epilepsy.  
 
Table 5-2 Measurements carried out with epilepsy patients. 
 
Patient 
Code 
 
 
Sex 
(m=male, 
f=female) 
 
Age 
 
 
Diagnosis 
 
 
History 
 
Evaluation 
Measurements 
 
Standard 
Training 
sessions 
 
Sessions 
with 28 
channels 
EEG 
 
Transfer 
sessions 
 
Feedback 
Electrode 
Feedback Type 
 
V=visual 
A=audio 
C=combined 
Task 
Declaration 
 
V=visual 
A=audio 
    (years) 1 2 3 (#) (#) (#)    
P1MH f 51 Focal epilepsy (focal 
seizures) 
45 + + - 78 5 3 Cz V A 
P2WM m 47 Focal epilepsy 
(complex focal and 
secondary generalized 
seizures) 
44 + + + 264 13 11 Cz V, A, C V, A 
P3GM f 31 Focal epilepsy 
(complex focal and 
secondary generalized 
seizures) 
30 + + + 112 3 - Cz V, A, C V, A 
P4ES f 52 Focal epilepsy (focal 
and complex focal 
seizures) 
49 + + - 76 4 - C4 V A 
P5RB f 33 Focal epilepsy(focal 
and generalized seizures) 
21 + + + 276 3 - Fz V, A, C V, A 
P6MU m 41 Focal epilepsy (focal 
and generalized seizures) 
27 + - - 27 - - Cz V A 
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6 Signal Processing for Feature Extraction and 
Quantification 
The electrophysiological signals acquired according to the evaluation measurement 
protocol introduced in chapter 4 (Table 4-1) need to be processed for a quantification 
of the relevant measures (i.e., the features). The procedure can be illustrated in a block 
diagram (Fig. 6.1): 
 
Data Acquisition
Signals
N
E
U
R
O
R
P
O
F
I
L
E
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Feature Quantification
 
Fig. 6.1 Block diagram of the analysis process. 
In this chapter, two stages of the analysis process, which comprise the signal 
processing tasks, will be elucidated: Feature extraction and feature quantification.  
The possible measures which can be extracted from the acquired data from different 
measurements are numerous. Based on the discussions in chapter 3, two groups of 
features will be focused upon for quantification because of their priority in epilepsy 
diagnostics and relevance to SCP based neurotherapy:  
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a. Epileptic graphoelements, which can possibly occur in any EEG measurement, 
will be studied for their clinical priority in epilepsy diagnosis. Depending on the 
occurrence frequency of such epileptic patterns, long-term EEG monitoring may 
be required. Via activation methods such as hyperventilation, the occurrence 
probability of such patterns in EEG is increased. Therefore, the measurement 
Standard I (Table 4-1) will be considered for the graphoelements analysis. 
b. DC-shifts and other related neurophysiological features will be studied for their 
relevance to SCP based neurotherapy. Considering CNV under the category 
“DC-shifts”, we will focus on the S1-S2 paradigm measurements, as well as the 
hyperventilation activation method for analyzing the associated DC-shifts. 
Changes in IHR resulting from hyperventilation will be analyzed as an 
additional measure based on the hypothesis by Jäntti and Yli-
Hankala [58], [59] discussed in section 2.4.5. 
Next, the methodology necessary for signal processing will be introduced for the 
extraction (or detection) and quantification of the selected features.  
6.1 Epileptic Pattern (Graphoelement) Analysis 
Epileptic patterns in EEG are characterized by distinctive transient waveforms such as 
spikes, sharp-waves, spike wave complexes, slow spike wave complexes and 
polyspikes. A spike is a transient with a pointed peak at conventional paper EEG 
speeds with a duration of 20-70 ms, and a sharp wave is defined similarly but with a 
duration of 70-200 ms. The slower transients may occur individually or accompanying 
the spikes. A spike wave-complex defines a slow wave (250-350 ms) following a 
spike [75].  
The percentage occurrence of any epileptic activity in an EEG measurement can be 
regarded as a feature for objective therapy evaluation. In order to achieve a 
quantification of similar patterns or certain selected patterns in a given data set, we 
suggest two approaches (Fig. 6.2):  
a. Supervised, and  
b. Unsupervised pattern analysis.  
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Supervised detection is based on the assignment of a representative epileptic pattern by 
an expert (i.e., supervisor) on the real data. Similar patterns are then searched for in the 
EEG recordings. On the other hand, in the unsupervised approach, the EEG is 
segmented adaptively and the segments obtained are classified by a clustering 
algorithm. Both approaches require measures to characterize the patterns in EEG. 
 
Quantification of Epileptic Patterns in EEG
EEG
channels
Signal conditioning / Pre-processing
UNSUPERVISEDSUPERVISED
Measure(s) selection for 
pattern characterization
Statistical analysis for percentage occurrence
Detection of similar 
patterns
Clustering of the obtained 
segments
Pattern assignment by a 
supervisor Adaptive segmentation
 
Fig. 6.2 Supervised and non-supervised strategies for quantification of epileptic patterns. After pre-processing, 
measures need to be assigned for pattern characterization in both approaches. In the supervised path, 
the supervisor selects the pattern of interest from the real data, and subsequently similar patterns are 
searched for in the data. In the unsupervised path, EEG is segmented adaptively and the segments 
obtained are clustered by a classification algorithm. 
6.1.1 Measures of Pattern Characterization in EEG 
The performance of both supervised and unsupervised approaches depends highly on 
the measure(s) used, because these measures determine either the segments obtained in 
adaptive segmentation in the unsupervised approach or, respectively, the pattern to be 
recognized in the supervised approach. Measure(s) should be able to characterize 
patterns in EEG distinctively. 
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6.1.1.1 Värri Measures 
Different measures can be used for this purpose. In an earlier study [76], a measure of 
spectral density calculated via FFT was used in the context of adaptive EEG 
segmentation. Because of the computational inefficiency in huge data sets, Värri [77] 
introduced an amplitude measure A (eq. 6.1) and a derivate measure F (which can be 
regarded as a measure of frequency) (eq. 6.2) for pattern characterization in EEG.  
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where xi is the i
th data point, j is the first data point in the analysis window of the length 
wl (in data points). These two measures will be referred to as Värri measures (VM). 
6.1.1.2 Fractal Dimension 
In the current work, fractal dimension (FD) is investigated as a new measure for 
detecting epileptic patterns, and its performance is compared with VM. 
FD is commonly applied in both system and signal analysis. In non-linear system 
analysis, it is used for representing attractors which have fractional dimensions. The 
algorithm most commonly used for this purpose is the Grassberger and Proccacia 
method [78]. In signal processing, FD was investigated for its ability to detect non-
stationarities in time series. It has been shown to be a useful tool for detecting 
transients in biomedical signals including EEG, as well [79], [80]. The changes in FD 
were shown to characterize changes in EEG due to alterations in the physiological state 
of the brain, not only in normal, but also in pathological functioning like epilepsy. Thus, 
in this study, the FD is also tested for its performance in pattern characterization. 
In the study by Esteller [81], the most prominent methods are compared for FD 
computing in EEG analysis. It is concluded, that the Katz algorithm is the most 
consistent method for the discriminating epileptic states from intracranial EEG. 
Therefore, we selected the Katz algorithm for fractal dimension calculation in our 
application. According to Katz, the FD of a curve is defined as: 
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where L is the total length of the curve, and r is the diameter estimated as the distance 
between the first data point and the data point that gives the largest distance. 
Normalizing the distances by the average distance between successive data points y, 
the eq. (6.4) is obtained. 
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Defining n=L/y, the number of steps in the curve, we get eq. (6.5), 
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For FD calculation Katz algorithm is implemented and tested on simulated data which 
is produced using the deterministic Weierstrass cosine function [82]: 
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where ω  > 1 and H, 0 < H < 1, is the constant determining the FD. Accordingly, the FD of 
the generated signal is given by FD=2-H. 
6.1.2 Supervised Quantification of Epileptic Patterns in EEG 
The supervised approach (Fig. 6.1), which is, to our knowledge, not addressed in this 
form in the literature, aims at automatic detection of a priori assigned patterns in EEG. 
The assignment has to be done by a supervisor on the real data. Then, the patterns, 
which are within a given tolerance similar to the original ones, are detected for further 
statistical analysis.  
The method used for pattern recognition is a template matching algorithm based on a 
data window containing the template (i.e., the assigned measure(s) calculated for the 
selected pattern) that moves along the signal. The window length of detection is the 
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same as the window length of the selected pattern. The measure(s) in the current 
window of analysis is (are) compared with those in the original one. When the 
difference between the current window and the reference pattern is smaller than an 
assigned tolerance, then a pattern is assumed to be recognized. After selection of the set 
of patterns to be recognized, two parameters need to be assigned in the developed 
approach: a. window overlapping, b. the maximum allowed error (E). 
The measure used for comparison of the patterns is the Euclidean distance,  
 ...)()()( 222 jpjpjpj ccbbaaD −+−+−=  (6.7)
where ap, bp, cp are the measures of the selected original pattern, aj, bj, cj are the measures 
of the pattern in the jth window analyzed, and D is the Euclidean distance. If Dj  ≤  E, 
then the pattern in the current window j is recognized as a similar pattern. E is 
assigned according to empirical results. 
The percentage epileptic pattern occurrence (%EPO) is not assigned via the number of 
patterns detected, rather via the ratio of the sum of the duration of similar patterns to 
the total duration of the measurement: 
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where %EPOi is the percentage occurrence of the i
th pattern, T is the over-all duration of 
the measurement, tij is the duration of the j
th similar pattern, n is the total number 
detected similar patterns, and  m is the number of distinctive patterns.  
6.1.3 Unsupervised Quantification of Epileptic Patterns in EEG 
Though not identified as “unsupervised quantification”, adaptive segmentation and 
clustering of obtained EEG segments have been found to be a convenient solution to 
the problem of visual inspection of huge EEG data sets [76], [83], [84]. The term 
“unsupervised quantification” is coined in this study, since the segments to be classified 
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are not defined a priori by a supervisor, but rather are obtained through an adaptive 
process.  
6.1.3.1 Adaptive EEG Segmentation Algorithm 
The adaptive segmentation approach, which is selected for its proved efficiency in other 
studies [77], [84], has been proposed by Silin and Skrylev [76]. The procedure  uses two 
successive windows moving on the time series in which the selected feature(s) is/are 
calculated. A measure difference function G is obtained through the difference of 
measure(s) in the two successive windows. The adaptive segment boundaries are then 
assigned to be the local maxima of G.  
As proposed in [77], [84], the difference measures, ADIF and FDIF in eq. (6.9), 
computed from the successive windows, are derived from the VM in eq. (6.1) and 
eq. (6.2),  
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where j and k are the data points, wl is the window length and ol is the overlapping of 
the successive windows (both in sample points).  
Accordingly, the corresponding difference function GV is obtained as 
 k a k f kGV c ADIF c FDIF= ⋅ + ⋅  (6.10)
where ca and cf are coefficients for amplitude and frequency measures respectively. The 
suggested values for the coefficients are ca = 1 and cf =7 in the literature [84], [85].  
In the adaptive segmentation application, the FD was assigned as a single measure for 
the function G. Thus, the corresponding difference function GD is obtained as  
    , k j kGD FD FD k j wl ol= − = + −  (6.11)
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where, similar to eq. (6.9), j and k are the data points, wl is the window length and ol is 
the overlapping of the successive windows (both in sample points). 
The Threshold in the Algorithm  
In order to avoid excessive segmentation due to redundant small segments, Krajca [84] 
introduced a threshold for the measure difference to the algorithm. The local maxima of 
the function G, which are over an assigned threshold, are assumed to position the 
segment boundaries. The threshold TH proposed in [84] is computed within the 
incoming block B of analysis as: 
 
1 ( )a B f BTH c A c FB
= ⋅ + ⋅  (6.12)
where AB and FB are the measures calculated for the whole block of analysis; ca and cf are 
the corresponding coefficients as in eq. (6.10).  
For achieving a higher adaptability of the threshold to the signals, an adaptive recursive 
approach was used in the current work. The threshold function Qn is obtained 
according to eq. (6.13) 
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where n is the number of steps in the function G with N number of points; ac, 0 ≤ ac ≤ 1, is 
an adaptation constant and α, 0 ≤ α ≤ 1, is the quantile parameter. The details on the 
adaptive recursive threshold can be found in [87]. 
6.1.3.2 Clustering the Obtained Segments 
The next step of the unsupervised approach is clustering the obtained segments. Due to 
the fact that the conventional clustering methods have the drawback of disjunctive 
classification, which does not apply to EEG, we follow the suggestions in [84] and use a 
fuzzy clustering algorithm. In a fuzzy classification, the patterns can have different 
degrees of membership in different classes at the same time. 
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Below, the FCMI algorithm used according to [86] and its application to EEG segments 
will be explained: Given a group of segments U={p1, p2,…,pm}, it is assumed that a 
specific number c of clusters exist. The centers of the clusters are unknown and the 
initial values y10, y20,…,yc0 are given. In our application, these initial points are set 
according to the measures of the first c segments of the first channel analyzed. 
Segments of each EEG channel are clustered separately. 
After each iteration, the membership values of a pattern to the corresponding clusters 
are obtained. The cluster centers are then updated by minimizing the local fuzzy 
performance indices If(i) of eq. (6.14). The process is terminated when the difference 
between two consecutive iterations does not exceed a given tolerance or when the 
current iteration is equal to the maximum number of iterations allowed (i.e., an upper 
boundary for avoiding infinite loops).  
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where If(i) is the i
th local fuzzy performance index and Pij denotes the grade of 
membership of pattern pj to the iteratively updated c number of clusters with the 
centers zi. m is the number of patterns (i.e., obtained EEG segments). 
The details of the used fuzzy clustering algorithm according to [86] are as follows: 
Input:   f, the segments dimension (number of measures). 
  m, the number of segments. 
  c, the number of clusters. 
  U = {pi}, 1 ≤ i ≤ m, the given segments in Rn. 
  Y0 = {yi0}, 1 ≤ i ≤ c,  the initial c cluster centers. 
  M, maximum number of iterations allowed. 
  ε, a given tolerance. 
β, a tuning parameter which controls the degree of fuzziness in the 
process. 
 
Output: Y = {yi}, 1 ≤ i ≤ c, the final c cluster centers. 
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  (Pij), 1 ≤ i ≤ c, 1 ≤ j ≤ m, the final matrix of membership values. 
  it, the number of iterations performed. 
 
Step 1.   Initialization: set k = 0 and yi
(0) = yi0, 1 ≤ i ≤ c. 
Step 2.  For 1 ≤ i ≤ c and 1 ≤ j ≤ m calculate 
 ( ) ( )k kij j ie p y= −  (6.15)
Step 3.  For 1 ≤ i ≤ c and 1 ≤ j ≤ m calculate 
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Step 4.  If eij
(k) = 0 for some l = l0, set Pl0j
(k) = 1 and Pij
(k) = 0 for all i ≠ l0. For 1 ≤ i ≤ c 
update the cluster centers, using eq. (6.17) 
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Step 5.  If 
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set yi = yi
(k+1), 1 ≤ i ≤ c; Pij = Pij(k), 1 ≤ I ≤ c, 1 ≤ j ≤ m; it = k+1; output yi, Pij for 
1 ≤ i ≤ c, 1 ≤ j ≤ m and stop. Otherwise continue. 
Step 6.  If k = N output ‘no convergence’ and stop. Otherwise, set k ← k+1 and go 
to Step 2. 
6.2 Contingent Negative Variation Analysis 
The data acquired upon the employment of the modified S1-S2 paradigm (section 4.2) 
are segmented according to the type of S2 (i.e., aversive or non-aversive) for extracting 
the sweeps of trials. The contaminated trials are excluded from the analysis. The 
artifact free sweeps are then averaged in time. Excluding the auditory evoked response 
(i.e., the first 200 ms after the presentation of S1), the mean value of amplitude of CNV 
is calculated within the time interval 0.2-6 sec after S1 for the interval, t1, and after S2 
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for the interval, t2 (see Fig. 4.4). The steps followed in the sweep based analysis of the 
employed S1-S2 paradigm, in order to extract CNV quantitatively, are given in Fig. 6.3. 
 Measurement ERP 2
(Table 4.1)
Segmentation according to S1
(sweep extraction)
Artefact correction / rejection
Channel selection
Baseline correction
Sweep averaging in time
Low-pass filtering 
(cut-off: 6 Hz)
Mean value calculation within 
t1 and t2 (Fig. 4.4)
Quantitative Results
(dCNV)  
Fig. 6.3 Signal processing steps for quantification of CNV. 
As the quantitative measure dCNV, the difference between the mean value of CNV and 
the mean value of the post S2 interval (i.e., t2 ) response, is assigned  
 = (CNV)- (Post_S2)CNVd mean mean  (6.19)
The quantitative results obtained corresponding to aversive and non-aversive S2 are 
statistically compared between healthy controls and epilepsy patients. 
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6.3 Analysis of Hyperventilation Induced DC-Shifts 
In order to investigate the DC shifts during the hyperventilation measurements, the 28 
channel EEG signals are averaged in time within a window length of 4 sec without 
overlapping through the measurements. The rate of change of the DC level is calculated 
via linear regression within the hyperventilation (shv) and recovery (srec) intervals. The 
slopes of the DC shifts, corresponding to the fitted lines, are assigned as quantitative 
measures. The flow diagram of the DC-level analysis during and after hyperventilation 
is given in Fig. 6.4. 
 Measurement Standard I
(Table 4.1)
Averaging in time
(window length= 4 sec)
Linear regression within the 
HV and recovery intervals 
Channel selection
Quantitative Results
(shv and srec)
Rate of change of DC-levels  
 
Fig. 6.4 Signal processing steps for quantification of hyperventilation induced DC-shifts. 
A percentage DC recovery index (DCIrec) is calculated from the parameters shv and srec as 
in eq. (6.20).  
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sDCI
s
⎛ ⎞
= − ×⎜ ⎟⎝ ⎠
 (6.20)
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6.4 Analysis of Hyperventilation Induced Changes in 
Instantaneous Heart Rate 
For extracting parameters reflecting the changes in IHR resulting from 
hyperventilation, R-peaks of the simultaneously acquired ECG channel are detected 
automatically by a QRS detector which is optimized for different sampling rates. The 
QRS detector is based on the basic principle of a peak detector, whereby it has a 
distinguishing approach of exploiting both the rising and falling edges of the 
R-peak [88]. IHR is calculated at each R-peak from the succeeding R-R interval. The 
R-R intervals are then linearly interpolated. Fig. 6.5 shows the analysis steps for 
obtaining IHR curves (IHRC) and for parameter quantification. 
The average HR values are extracted from IHR curves (IHRC) within three intervals, 
(1) before hyperventilation, the baseline reference value, (2) during hyperventilation, 
and (3) during recovery intervals as in eq. (6.21).  
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where notation bsl (baseline) denotes the 3 minute  interval before hyperventilation, hv 
denotes the 3 minute hyperventilation interval, and rec denotes the 3 minute interval 
after hyperventilation (i.e., recovery). 
From the average IHR values obtained (i.e., HRbsl, HRhv, HRrec), two indices are calculated 
for quantifying changes in the heart rate: The heart rate recovery ratio (HRrec/hv) and the 
hyperventilation heart rate index (HRIhv), which are given in percentage in eq. (6.22) 
and in eq, (6.23), respectively. 
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 Measurement Standard I
(Table 4.1)
Signal conditioning
Automatic R-peak detection
ECG channel
Quantitative Results
(HRbsl, HRhv, and HRrec)
Calculation of R-R intervals
IHR calculation
Assigment of the values to the 
preceding R positions
Linear interpolation in R-R 
intervals (IHRC)
Average heart rate in HV, 
recovery and pre-HV intervals
 
Fig. 6.5 Signal processing steps for IHR calculation during hyperventilation. 
The obtained results of IHR analysis are combined with the results of DC analysis for 
comparisons between patients and controls. 
 
7 Software-Technical Aspects as a Basis for 
Automation 
A software technical approach is necessary, not only for processing the acquired signals 
for feature extraction and quantification, and subsequent analysis, but also for 
recording the supplementary medical information such as the seizure calendar and 
verbal results of clinical examinations, there is the need of an information technological 
approach. For a possible automation of the signal processing options, a software 
concept has been developed within the scope of current study. If the dimensions of the 
neuroprofile and the additional clinical data are considered, the information to be 
processed in therapy evaluation is immense. In order to solve the problem of managing 
the excessive amount of data, a database system, which is linked to the signal 
processing software, has been planned, designed and implemented. 
Even though the current study concentrates on epilepsy, the system introduced in 
chapter 5 is also applicable to other neurological disorders, such as attention deficit 
disorder (ADD), ADHD, depression and sleep disorders. Therefore, in the 
conceptualization of the software and the database, applicability and extension to 
other neurological diseases in the realm of neurotherapy, is taken into account. The 
database system developed is presented in [89]. 
7.1 The Neuroprofile Extraction Module 
In order to extract the selected parameters of the neuroprofile, the components of 
signal processing procedures introduced in chapter 6 (i.e., for supervised and 
unsupervised epileptic pattern analysis and fuzzy clustering; for DC-level analysis 
during hyperventilation and thereafter, as well as CNV; and for IHR analysis) are 
integrated in a software concept. The software concept of the neuroprofile extraction 
module is illustrated in Fig. 7.1. Different procedures of signal processing, implemented 
as sub-modules in Matlab, are integrated in the structure.  
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The module reads polygrahic data (i.e., EEG, ECG, VEOG; HEOG, respiration curve) of 
different formats from different systems (e.g., BrainQuick and NeuroScan). A graphical 
user interface (GUI) (Fig. 7.2) enables interactive presentation of data and results of 
analyses. There is a separate sub-module is developed for signal conditioning (i.e., pre-
processing, e.g., downsampling, artefact rejection and/or correction). The analysis 
module, which contains the feature extraction and quantification components, is the 
central element in the concept. The current version of the neuroprofile extraction 
module can extract 
a. graphoelements and their corresponding statistics from clinical EEG, 
b. DC-shifts in EEG accompanying provocations such as hyperventilation and 
apnea,  
c. parameters corresponding to event-related potentials (e.g., amplitude of CNV), 
and 
d.  parameters of simultaneously acquired polygraphic signals (e.g., IHR and 
respiration rate).  
 
READ DATA
Reading data of 
different formats
ANALYSIS MODULES
(e.g., adaptive segmentation, 
DC-level analysis, frequency 
analysis, CNV and p300 
analysis)
POLYGRAPHIC DATA
GUI
Interactive presentation 
of the data
QUANTITATIVE 
RESULTS
PRE-PROCESSING
(e.g., artifact rejection 
and/or correction, signal 
conditioning)
DATABASE SYSTEM
RESULTS
PRESENTATION
 
Fig. 7.1 Software components and flow diagram of the neuroprofile extraction module. Polygraphic data of 
different formats are read, interactively presented, and pre-processed for the main analysis, which 
contains software components for extraction of the relevant parameters. The quantitative results are 
stored in proprietary files. © IEEE Transactions on Information Technology in Biomedicine. 
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Fig. 7.2 Graphic User Interface of the Neuroprofile Extraction Module. 
The quantitative results obtained from the analysis module are saved in a pre-defined 
format in a file system. These results can be recalled and presented either as curves or 
statistics or, for EEG, as topographic mappings. The details on the realization of the 
software components for epileptic pattern analysis can be found in [90]. At a further 
stage of development, a database system was developed in order to manage the 
obtained quantitative results.  
7.2 Database Development 
For systematically managing the extracted quantitative features resulting from the 
developed software components, as well as the supplementary medical information, a 
database system was planned, designed and implemented: 
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7.2.1 Methodological Concerns 
According to the ANSI-SPARC8 model, three levels of abstraction can be distinguished 
during the database design process [91]. At an external level the real world’s cutout to 
be modeled is structured, and the database is described from each user’s point of view. 
The resulting external user views are merged at the conceptual level into an integrative 
conceptual database scheme that describes the database structure for all types of users. 
It contains information about the objects modeled by the database, their properties, the 
relations between objects and constraints derived at the external level. Finally, the 
internal level describes the parameters of the database management system used to 
implement the database model. As a result, the physical structures of the database are 
determined by the internal scheme.  
Fig. 7.3 shows the database design process and the corresponding generated 
documents [92], [93]. The requirements specification obtained after the requirements 
analysis documents the needs of the user(s). This specification is formalized by a 
conceptual database scheme, which is the outcome of the conceptual design. The 
logical design process transforms the conceptual scheme into the data model of the 
target database management system, the parameters of which are determined by the 
physical design process. The whole design process and its results are finally 
documented by the data dictionary. 
7.2.2 Database Planning 
7.2.2.1 Requirements Analysis 
The requirements analysis can be divided into two components: the information 
requirements and the functional requirements. Functional requirements include the 
dynamic processes which are expected to be carried out by the database: The 
transactions (the requests, evaluations, and report generations) which are to be 
realized through the system, and the corresponding access regulations for different 
types of users belong to functional requirements. The information requirements, on the 
other hand, include the static information, which the database system will contain. The 
                                                         
8 American National Standards Institute, Standards Planning and Requirements Committee.  
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objects of the real world with their properties, types and ranges, their relationships and 
integrity conditions refer to information requirements.  
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Fig. 7.3 The database design process according to [92]. © IEEE Transactions on Information Technology in 
Biomedicine. 
The information requirements will be discussed in detail, since the current study is 
concerned with the extraction of essential features; both quantitative (results of the 
signal processing procedures) and verbal data (the verbal clinical information and 
seizure calendar, which can be quantified in a knowledge-based approach in further 
studies). The clinical relevance and priority are considered for the data concept. 
The database is expected to combine two types of information which are inherently 
different: The quantitative data is well structured, purely numeric and extensive. In 
contrast, the medical information is rather unstructured, verbal and concise. The 
combination of these two types of information makes the design process demanding. 
Therefore, from the information technology point of view, the database to be 
conceptualized is not an operational system but a data warehouse [94], [95]. It 
regularly collects data from different sources (residing in different places using 
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different formats) and concentrates them in the database warehouse. The data are 
integrated in advance, meaning the necessary information are fetched, filtered, 
processed, consolidated and stored in the warehouse prior to the analyses being done. 
In order to provide the data necessary for a specific analysis none of the original data 
sources have to be accessed again. 
Due to the consideration that the database can be extended to further disorders, it 
needs to be structured in two parts: a disorder-independent and a disorder-specific 
division (Fig. 7.4). The first version of the database contains the epilepsy-specific 
component, which is related to the content of the current study. Further versions can 
be supplemented with other disorder-specific components. 
The database has to contain information regarding not only the patients but also 
healthy controls, so that comparisons with the norms will be possible. The control 
subjects (i.e., probands) are assured not to have any registered neurological disorder. 
This is tested via an inventory of yes/no questions. Thus, inter-group comparisons of 
the neuroprofiles (considering factors such as age, sex and handedness) shall also be 
done when a statistically significant number of control subjects and patients are 
obtained. The data warehouse, which will be introduced next, is conceptualized 
according to these requirements. 
7.2.2.2 Data Warehouse Outline 
Fig. 7.4 shows the outline of the data warehouse. Apart from the distinction between 
disorder independent/specific components, the database can be divided into five parts, 
each of which contains information essential for therapy evaluation purposes. 
General information 
This part contains information that is collected for both patients and control subjects. 
It incorporates personal data (identity code (ID), birth date, sex etc.), the 
neurofeedback sessions done along with their parameters and a list of EEG 
measurements performed. The polygraphic raw data are not included in the database; 
rather they are linked to the system over a file-system due to their large size and 
quantity. 
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Fig. 7.4 Datawarehouse outline. © IEEE Transactions on Information Technology in Biomedicine. 
Control subject information 
This information is vital to ensuring that the control subjects have no neurological 
disorders that would disqualify them from being considered healthy for our 
investigations. It includes yes/no questions about any history of head injury, alcohol 
addiction, drug abuse, or neurological disorders (see Appendix A).  
Patient (epilepsy) information 
This division documents a detailed history of the patients’s disorder and the 
treatment(s) applied. In the case of epilepsy, it includes the type of epilepsy, its 
classification and symptomatic, the seizure types, a list of occurred seizures (seizure 
calendar), all treatment modalities apart from neurotherapy (pharmacotherapy, surgery 
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etc.), clinical examination results, and measurements performed along with their 
results and findings. Summarized inventories can be found in Appendix B. Future 
extensions in this division will include supplements with specific information related 
to other neurological disorders.  
Quantitative data 
This part constitutes the largest part of the database. It contains the components of the 
neuroprofile (i.e., the measures addressed in chapter 6, qEEG and other quantitative 
parameters extracted from polygraphic signals).  
Auxiliary data 
This section contains data used by the other parts of the database, such as a list of 
antiepileptic medication that can be prescribed, possible electrode positions, and 
provocations. 
7.2.2.3 Software Concept 
Fig. 7.5 illustrates the integration of the database into the applications and the data that 
remain outside the database. The parts of the concept that will be completed in the 
future are marked with dashed lines (see Fig. 7.5). 
Due to their size, acquisition and storage modalities, it is preferable not to store the 
polygraphic raw data in the database, but rather to maintain them in an encrypted 
directory structure on a file server. Based on the type of EEG session 
(diagnostic/therapy), the date of the recording and the patient’s or control subject’s ID, 
the file name and the directory in which the data are stored, are coded. The database 
only contains a list of the recordings done for a particular person. At the first stage of 
implementation (Fig. 7.5), calculation of the quantitative parameters and extraction of 
relevant features are done both by the implemented sub-modules of the neuroprofile 
extraction module (Version I) and by different commercial software packages. The 
obtained results are stored in proprietary files.  The wrapper, a converter program 
accessing the database via ODBC or embedded SQL, stores the content of the 
proprietary files in the database. 
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Fig. 7.5 Software concept using the database. 1st development stage (current): Quantitative results are extracted 
both by the implemented sub-modules of the neuroprofile extraction module (version I) and the 
commercial software packages. They are entered into the data warehouse via a wrapper. Database 
frontend is used for maintenance of supplementary medical information. Results stored in the data 
warehouse can be visualized or statistically analyzed by the corresponding modules which have access 
via embedded SQL or ODBC. 2nd development stage (future): Neuroprofile extraction module (Version II) 
shall overtake the quantitative analysis completely and store the results directly into the data warehouse. 
© IEEE Transactions on Information Technology in Biomedicine. 
At a later stage of development, the commercial software packages will be completely 
substituted with the neuroprofile extraction module (Version II), which is still under 
development. Version II will have direct access to the database, thus the temporary 
storage of the results in proprietary files will become obsolete. This will not only enable 
the usability in different clinics, but also hasten the automation. The maintenance of 
non-quantitative data is accomplished by means of a database frontend. It shall be done 
by the medical-technical personnel who apply the therapy.  
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7.2.3 Design and Implementation 
Having analyzed the requirements, the database development process is continued 
with the design and implementation. Corresponding steps of conceptual, logical and 
physical design (Fig. 7.3) will be addressed next: 
7.2.3.1 Conceptual Design 
The objective of the conceptual design process is to describe the cutout of the real 
world that is to be modeled by the database in a formal way, independent from the 
characteristics of the target database management system. In most cases it is done 
using Entity-Relationship Modeling (ERM) [96].  
In ERM, physical or virtual objects and concepts of the real world are termed as 
entities. Similar entities are abstracted by entity types and clustered in entity sets. 
Likewise, similar relationships between entities are abstracted by relationship types 
and clustered in relationship sets. The entity sets are universally characterized by 
attributes which describe the owner’s properties, whereas the relationship sets may or 
may not have attributes. Functionality and cardinality are two other elements which 
belong to the description of the real world. They quantitatively define the links 
between the entity sets which are connected via relationships. By means of these 
elements, a real world system can be modeled in an entity-relationship diagram 
(ERD) [93], [96]. 
Thus, the data warehouse outline described above is given full particulars in a global 
ERD. The five parts of the database are modeled with all of their details and linked 
together adequately. Fig. 7.6 shows a small part of the final diagram. The overall ERD 
contains many more entity types which relate to person, proband, epilepsy patient or 
diagnostic raw data. 
7.2.3.2 Logical Design 
The aim of this step of the design process is to map the conceptual database scheme 
into the data model utilized by the target database management system (DBMS) [97]. 
The data model is the paradigm used by the database to store information. Currently 
there are three types of data models used by databases. The relational data model is the 
prevalent model used by most databases. The object-oriented model integrates aspects 
7  Software-Technical Aspects as a Basis for Automation 72 
of software development into the database world and is more flexible. The object-
relational model [98] is a hybrid of both which combines the sophisticated mechanisms 
of relational databases with the advanced features of object-oriented databases. 
Because of the fact that most of the warehouse contents have a simple structure that 
can be modeled easily with relations, the object-relational data model was chosen for 
the warehouse. The three-dimensional structure of the neuroprofile (Fig. 4.1) can be 
adequately mapped into multi-dimensional arrays. 
As a result of logical database design, a list of relations was produced from the 
conceptual scheme. The entity and relationship types of the ERD became relations 
(see Fig. 7.6). As an example, the “epilepsy patient” entity type was mapped to the 
relation “epilepsy patient” (i.e., ID, employed, patient history, family history, epilepsy 
type, epilepsy classification, focus, position, photosensibility exists, photosensibility 
description). 
7.2.3.3 Physical Design 
This last step addresses the internals of the database system. It comprises the choice of 
the target database management system, the definition of the structures used to store 
the information, the mechanisms used to speed up searches, the implementation of 
constraints that ensure a consistent data stock, and the management of access 
rights [99]. 
As the target system several candidates (Borland [100], Frontbase [101], mySQL AB 
[102], and Postgres [103]) were compared in facilities such as administration, interface 
options, network capability, multi-user option, and costs. Finally, the PostgreSQL9 was 
chosen: It is an open-source object-relational database system which offers a variety of 
object-relational features. Apart from its sophisticated mechanisms to enforce data 
consistency and its ability to handle large amounts of data, it has the advantage of being 
free, compared to the expensive commercial database servers. For the enforcement of 
data consistency domain constraints, functions and rules were used. 
                                                         
9 PostgreSQL was developed at the University of California at Berkeley. 
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Fig. 7.6 A sample part from the entity-relationship diagram. Person, proband and epilepsy patient are central 
entity types of the model. Neurofeedback represents a session of neurofeedback training performed with 
a person, diagnostic raw data is a set of EEG data recorded for a particular person. © IEEE Transactions 
on Information Technology in Biomedicine. 
7.2.3.4 Realization 
The PostgreSQL 7.1.2 database server was set up on a Windows 2000 Workstation. 
Since PostgreSQL supports only Unix-like operating systems, the emulation Cygwin had 
to be used to provide PostgreSQL with a Unix platform [103]. The emulation is only 
required by the machine that runs the server; the client machines may run any 
Windows operating system.   
Although using the PostgreSQL server on a Linux machine can be more efficient, a 
Windows based solution is preferred because of the fact that our medical partners 
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mainly use Windows operating systems, and the software components of the developed 
EEG-biofeedback system are also Windows based.  
As shown in Fig. 7.5, at this first stage of the development several applications are used 
to enter data into the warehouse: The quantitative data are inserted by the wrapper 
which gets access via ODBC, whereas the non-quantitative information needs to be 
entered manually by means of the database frontend, the Neurobase (Fig. 7.7), which is 
implemented in Microsoft Access. The statistical analyses are carried out by the 
corresponding application (Fig. 7.5) which also has access to the database via ODBC. 
More details on the data warehouse realization can be found in [104]. 
 
Fig. 7.7 NeuroBase for entering clinical information. © IEEE Transactions on Information Technology in 
Biomedicine.
8 Results 
Having introduced our approach, measurements, methodology, and software 
realizations, the results10 obtained by application of the methods on real data will be 
presented next.  
8.1 Epileptic Patterns Analysis 
The performance of both supervised and unsupervised approaches to epileptic pattern 
detection depends primarily on the measure(s) used. The better the measures 
characterize epileptic activities, the higher the performance is. Hence, the performance 
of the measures for pattern recognition (i.e., VM as the previously used measures, and 
FD as a new feature introduced in this study) is tested and compared [105] in a set of 
randomly chosen epileptic patterns (n=30) from data acquired in previous studies. 
Representative results are illustrated on 3 sample patterns (Fig. 8.1-Fig. 8.3). For 
facilitation of comparison, the threshold for preventing redundant segmentation is 
assigned differently for each case as the value for which the highest number of 
redundant segments is eliminated, without missing the desired segment boundaries.  
8.1.1 Värri Measures versus Fractal Dimension 
When the performance of the features was compared in the 30 randomly selected 
epileptic patterns, 14 patterns (47 %) showed FD to be more sensitive to the end points 
of the patterns, whereas VM detected some redundant boundaries within the patterns 
before the end points were detected, as shown in Fig. 8.1 a, b. In 3 patterns (10%), VM 
failed to detect the segment boundaries correctly (Fig. 8.2 a), whereas FD was 
successful (Fig. 8.2 b). The results in the remaining 13 patterns were similar for both 
VM and FD. The detection results as shown in Fig. 8.3 a, b, are accepted to be equally 
successful. Based on these results, it was concluded that FD performs superiorly to VM 
in extracting epileptic patterns in EEG [105]. 
                                                         
10 Some partial results have been presented in different publications [89], [105]-[107]. 
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Fig. 8.1  Segmentation results for sample pattern 1, (a) Värri measures (threshold = 0.4 (*) and 0.45 (o)), (b) FD 
(threshold = 0.4). Window width = 1.1 sec, window overlapping = 60%. © IEEE Engineering in Medicine 
and Biology 
 
 
Fig. 8.2 Segmentation results for sample pattern 2, (a) Värri measures (threshold = 0.3 (*) and 0.4 (o)), (b) FD 
(threshold = 0.35). Window width = 1.1 sec, window overlapping = 60%. © IEEE Engineering in Medicine 
and Biology. 
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Fig. 8.3 Segmentation results for sample pattern 3, (a) Värri measures (threshold = 0.6 (*) and 0.75 (o)), (b) FD 
(threshold = 0.5). Window width = 1.1 sec, window overlapping = 60%. © IEEE Engineering in Medicine 
and Biology. 
There are further observations which need to be emphasized concerning the FD as a 
feature for adaptive EEG segmentation and epileptic pattern extraction [105]: The first 
observation is that FD decreases in epileptic pattern intervals (Fig. 8.1 b, Fig. 8.2 b, Fig. 
8.3 b). Secondly, FD is more sensitive to the end points of the epileptic patterns, and it 
is more stable within the pattern interval. If we assume that the brain switches from a 
higher dimensional “normal” state to a lower dimensional “pathological” stationary 
state in the epileptic pattern intervals, it can be stated that the FD, as a feature, better 
reflects these changes in physiological state. Another advantage of FD is that it can be 
used as a single measure without any weight coefficients in the adaptive segmentation 
algorithm eq. (6.12). On the other hand, FD was observed to detect more segment 
boundaries outside the pattern intervals than the VM. This was regularly observed in the 
sample patterns (Fig. 8.1-Fig. 8.3). Further discussion and investigations are required in 
order to determine whether these are redundant segment boundaries or really 
significant state changes.  
8.1.2 Supervised and Unsupervised Detections 
For supervised detection, the performance of the measures also reflects the performance 
of detection, since the patterns are assigned as “recognized” if the measures are within a 
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range of tolerance. The decisive parameter of the method is the tolerance E, which 
determines the recognition sensitivity. 
In addition to the measures, the efficiency of clustering is important to the overall 
performance in unsupervised quantification. Having concluded that FD is superior to 
VM as a feature for extracting epileptic patterns, it was applied to unsupervised 
quantification via fuzzy clustering. A sample analysis result is given for a channel of an 
EEG recording, in which epileptic patterns were observed. The number of clusters is a 
priori assigned as 6, according to experimental results on different data. 
 
Fig. 8.4 Sample results of fuzzy clustering after adaptive segmentation based on FD on an EEG channel. 
Statistics (percentage occurrence) of the clusters which have the corresponding FD value as the center. 
Based on the observation that FD decreases in epileptic pattern intervals, the clusters, 
which have lower FD values as their centers, should be considered epileptic pattern 
clusters: As seen in Fig. 8.4, cluster 6 (FD=1.82), cluster 4 (FD=1.99) and cluster 3 
(FD=2.14) should be considered possible epileptic pattern clusters. The medical expert 
must decide which clusters are to be accepted as such. Epileptic spike wave complexes 
are clearly seen in cluster 6.  
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The adaptive segmentation algorithm has three important parameters which need to be 
discussed: the window width, the percentage overlapping of the successive windows, 
and the threshold.  
a. The window width should not be selected larger than 1.5 sec in order to more 
accurately detect non-stationarities. It should also conform to the number of 
data points required to sufficiently calculate the selected feature. On the other 
hand, the smaller the window width, the higher the computational load.  
b. The overlapping has a similar effect to the algorithm: The longer the overlapping 
is (smaller step length), the greater the number of segments found. This means a 
longer computation time and an increase in the number of redundant segments. 
However, if the overlap is too small, the necessary segment boundaries to be 
detected can be missed.  
c. The threshold is the parameter which determines the sensitivity of the 
algorithm. The higher the threshold is, the less sensitive the algorithm is to the 
non-stationarities. If the threshold is too low, then the problem of redundant 
segmentation appears.  
The setting of all three parameters is a trade-off between topical sufficiency 
(respectively redundancy) and computational complexity. In our software 
development, these parameters can be input as desired so that their influence on the 
performance of the algorithm can be observed. Based on our empirical results, we 
recommend a window length of 1.1 sec at a sampling rate of 128 Hz, and a window 
overlapping of 60%. The software also allows the automation of the analysis where we 
assign the window width and the overlapping a priori according to experimental 
results. For automated analysis, the threshold for the segment boundary detection (i.e., 
for function G see section 6.1.3.1) is determined adaptive recursively according to the 
distribution of the normalized values of G through the data interval analyzed [87].  
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8.2 Differences in the Contingent Negative Variation between 
Patients and Controls 
The CNV measurements are analyzed according to the procedures presented in 
section 6.2. In order to enlarge the statistical pool, additional measurements from 
previous studies are integrated into the analysis. The data are analyzed for both the 
patient group (n=12) and healthy controls (n=11). Sample results from a control subject 
are illustrated in Fig. 8.5 for 28 EEG channels. 
 
Fig. 8.5 Sample CNV results for 28 EEG channels. Initial measurement of subject S1JN. Time average of 20 
sweeps. 
According to our results, CNV occurs after presentation of the warning stimulus S1, 
whereas positive DC shifts occur after the presentation of the stimulus S2 (Fig. 8.6). 
The topology of dcnv is demonstrated for a control subject (Fig. 8.7 a) and a patient (Fig. 
8.7 b). Comparisons of the central line electrodes Fcz, Cz, Cpz, and Pz between the 
patient group and the controls indicate significant differences (Table 8-1) [89], [106]. In 
the control group, the mean values of the CNV and the post-S2 level are significantly 
different at all electrode positions with exception of Pz in the non-aversive case, 
whereas in the patient group, these levels are significantly different only at the 
electrode position Cz in the aversive case (Wilcoxon-Signed-Rank-Test, p<0.05). The 
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dcnv for aversive stimuli is higher than for non-aversive stimuli in all subjects and 
patients in all channels at which CNV is clearly observed. 
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Fig. 8.6  Quantification of CNV results, dcnv. Subject S5PT, initial measurement, channel Cz. 
 
Fig. 8.7 Topological mapping of the measure dCNV from, a) control subject S2MN, initial measurement; b) epilepsy 
patient P4ES, pre-therapy measurement.  
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Table 8-1 CNV Comparison between patients and control subjects. © IEEE Transactions on Information 
Technology in Biomedicine. 
Results (p) 
Wilcoxon Signed-Rank-Test,  p<0.05 
 
Channel 
Patients 
Aversive case 
Patients 
Non-aversive case 
Controls 
Aversive case 
Controls 
Non-aversive case 
Fcz 0.077 0.204 0.001 0.005 
Cz 0.042 0.569 0.003 0.024 
Cpz 0.063 0.424 0.003 0.019 
Pz 0.110 0.569 0.010 0.413 
8.3 Differences in the Hyperventilation Induced DC-Shifts 
Hyperventilation induced shifts in DC-potentials are analyzed via the method 
introduced in section 6.3. In Fig. 8.8, a sample result of the DC analysis is given for a 
standard measurement from a control subject: 
  
Fig. 8.8 DC-level during a standard measurement for all EEG electrodes. Subject S5PT, initial measurement. 
Triggers: F6=HV-start, F7=HV-end, F4=recovery-end. 
As seen in Fig. 8.8, not all electrodes are stable (i.e., artifact free) along the 
measurement (e.g., P3). Nevertheless, a pattern appears, which can be extracted from 
the results within the hyperventilation interval and thereafter: The trigger F6 is the 
beginning and F7 is the end of hyperventilation, which continues for three minutes. The 
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trigger F4 points to three minutes after the end of hyperventilation. We define this 
interval as recovery. If we select the central electrode positions (Fz, Cz, Pz, and Oz) 
and also include other frontal (Fp1, Fp2) and occipital (O1, O2) electrodes, we obtain 
the following pattern in Fig. 8.9 for a control subject and Fig. 8.10 for a patient. 
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Fig. 8.9 DC-shifts during and after hyperventilation at electrode positions Fp1, Fp2, Fz, Cz, Pz, Oz, O1, and O2. 
t = 0, hyperventilation starts; t = 185 s, hyperventilation ends. Subject S5PT, 1st evaluation measurement. 
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Fig. 8.10 DC-shifts during and after hyperventilation at electrode positions Fp1, Fp2, Fz, Cz, Pz, Oz, O1, O2. 
t = 0, hyperventilation starts; t = 176 s, hyperventilation ends. Patient P2WM, pre-therapy measurement. 
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After the linear regression (Fig. 8.11), the quantitative parameters shv and srec are 
extracted. 
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Fig. 8.11 Linear regression for determining the rate of change of DC-level within HV and recovery intervals. 
The topographic distribution of the rate of change of DC-level at different electrode 
positions can be mapped as in Fig. 8.12 and Fig. 8.13. 
 
Fig. 8.12. Topological mapping of the rate of change of DC-level for a control subject (S1JN, initial measurement), a) 
hyperventilation (shv), and b) recovery (srec). 
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Fig. 8.13 Topological mapping of the rate of change of DC-level for an epilepsy patient (P2WM, pre-therapy 
measurement), a) hyperventilation (shv), and b) recovery (srec).  
As seen in Fig. 8.12 and Fig. 8.13, the highest DC-shifts, both in hyperventilation and 
recovery, are observed either at Cz and/or Fz. Therefore, the rate of change of DC-levels 
in HV and recovery intervals at the vertex (Cz) are compared between control subjects 
and epilepsy patients for those measurements in which the stability of the electrodes 
was satisfactory. The results at the central electrode positions (Fz, Cz, Pz and Oz) for 
the control subjects (Table 8-2) and for the pre-therapy measurements of the patients 
(Table 8-3) are given below:  
 
Table 8-2 Rate of change of DC-level within HV and recovery intervals for control subjects. 
Rate of Change of DC-level  
Subject 
Code 
Hyperventilation 
shv (µV/s) 
Electrode 
      Fz               Cz                Pz              Oz 
Recovery 
srec (µV/s) 
Electrode 
     Fz                 Cz               Pz               Oz 
S1JN -0.56 -0.60 -0.56 -0.29 0.40 0.48 0.18 0.05 
S2MN -0.18 -0.25 -0.16 0.01 0.21 0.31 0.20 0.04 
S3AD -0.34 -0.73 -0.05 0.60 0.47 0.58 0.22 -0.83 
S4OL -0.28 -0.43 -0.22 0.35 0.23 0.21 0.04 -0.35 
S5PT -0.51 -0.47 -0.34 -0.08 0.30 0.41 0.08 -0.01 
S6CR -0.57 -0.53 -0.53 -0.33 0.20 0.26 -0.00 0.03 
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Table 8-3 Rate of change of DC-level within HV and recovery intervals for  patients. 
Rate of Change of DC-level  
Patient 
Code 
Hyperventilation 
shv (µV/s) 
Electrode 
      Fz               Cz                Pz              Oz 
Recovery 
srec (µV/s) 
Electrode 
     Fz                 Cz               Pz               Oz 
P1MH -0.05 -0.17 -0.14 -0.09 0.10 0.27 0.29 0.09 
P2WM -0.50 -0.59 -0.31 -0.37 -0.11 -0.07 0.09 0.02 
P3GM 0.01 -0.50 -0.21 -0.12 0.22 -0.00 0.40 0.15 
P4ES -0.10 -0.17 -0.19 0.35 0.32 0.26 -0.00 -0.73 
P5RB -0.37 -0.40 -0.05 0.46 0.55 0.59 0.19 -0.90 
P6MU -0.76 -0.80 -0.37 -0.08 0.09 -0.14 0.06 -0.11 
 
Table 8-4 Percentage DC-recovery after hyperventilation in patients and controls. 
Patient Code % DCIrec 
at the vertex (Cz) 
Subject Code % DCIrec 
at the vertex (Cz) 
P1MH 159% S1JN 80% 
P2WM -12%, negative shift, no recovery S2MN 124% 
P3GM -0.8%, negative shift, no recovery S3AD 80% 
P4ES 153% S4OL 49% 
P5RB 148% S5PT 87% 
P6MU -11%, negative shift, no recovery S6CR 49% 
The results of the DC-level analysis during and after hyperventilation (Table 8-2, Table 
8-3) indicate that [107]:  
a. the observed negative DC shifts upon hyperventilation are highest at either Cz 
or Fz electrode position in both groups;  
b. positive DC shifts are observed at occipital electrodes in 3 control 
subjects (50%), and 2 patients (33%);  
c. the DC shifts tend to recover after the hyperventilation in the control group;  
d. in three patients (P2WM, P3GM, P6MU) (50%), the shifts tend to continue in 
negative direction (i.e., recovery is not observed) at the vertex (Cz). (Table 8-4); 
e. in the other three patients (50%), the percentage recovery at the vertex is much 
higher (Table 8-4, P1MH=159%, P4ES=153%, P5RB=148%) than the average of 
control group (78%). 
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8.4 Instantaneous Heart Rate and Hyperventilation 
Changes in the IHR resulting from hyperventilation are analyzed according to the 
procedure defined in section 6.4 in both groups. Sample results from a control subject 
and a patient are illustrated in Fig. 8.14 and Fig. 8.15, respectively. The first observation 
is that the increases in IHR resulting from hyperventilation have a non-linear character. 
Similarly, the decreases in IHR within the recovery interval show a non-linear 
character. Standard deviation of IHR within these intervals indicates subject specific 
variety. The results of HRbsl, HRhv, and HRrec, as well as %HRrec/hv and %HRIhv, are listed for 
control subjects in Table 8-5 and for patients in Table 8-6.  
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Fig. 8.14 IHR analysis result during HV and recovery for a control subject (S4OL). (a) the ECG channel after 
pre-processing from the standard I measurement, (b) the detected R peaks (an interval zoomed from (a)), 
(c) the corresponding IHRC.  
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Fig. 8.15 IHR analysis result during HV and recovery for a patient (P2WM). (a) the ECG channel after 
pre-processing from the standard I measurement, (b) the detected R peaks (an interval zoomed from (a)), 
(c) the corresponding IHRC. 
 
Table 8-5 Measures HRbsl, HRhv, HRrec and the indices %HRrec/hv and %HRIhv for control subjects in initial 
measurements. 
Subject 
Code 
HRbsl 
(beats/min) 
HRhv 
(beats/min) 
HRrec 
(beats/min) 
%HRrec/hv %HRIhv 
S1JN 93 107 93 13% 100% 
S2MN 78 89 75 16% 127% 
S3AD 84 129 95 36% 76% 
S4OL 65 104 71 32% 85% 
S5PT 71 109 90 17% 50% 
S6CR 61 78 62 21% 94% 
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Table 8-6 Measures HRbsl, HRhv, HRrec and the indices %HRrec/hv and %HRIhv for patients in pre-therapy 
measurements. 
Patient 
Code 
HRbsl 
(beats/min) 
HRhv 
(beats/min) 
HRrec 
(beats/min) 
%HRrec/hv %HRrec 
P1MH 68 71 69 3% 67% 
P2WM 72 79 74 6% 71% 
P3GM 67 76 71 7% 56% 
P4ES 58 62 57 8% 125% 
P5RB 68 85 73 14% 71% 
P6MU 83 105 98  7% 32% 
 
8.5 DC-Shifts and Instantaneous Heart Rate in Patients and Controls 
Combining the quantitative measures of EEG/DC-shifts and of the changes in IHR 
induced by hyperventilation, we obtain the following results illustrated in Fig. 8.16 and 
Fig. 8.17 for patients and controls:  
 
Fig. 8.16 srec at the vertex (Cz) versus %HRrec/hv in patients (PT) and controls (CS). 
As seen in Fig. 8.16, where the measure srec is plotted versus the index %HRrec/hv, the 
patients can be distinguished from the controls with a single exception.  
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Fig. 8.17 DCIrec at the vertex versus HRIhv in patients and controls. 
Using the indices %DCIrec and %HRIhv, we obtain another view (Fig. 8.17). Two clusters 
of patients (i.e., PT1 and PT2) can be distinguished from the controls (CS). There is a 
fourth cluster (OG) which includes a patient and a control subject. If we set a range for 
%DCIrec, for instance 30-130%, the controls can be placed in a zone between the patient 
groups.  
8.6 EEG-Biofeedback Adjustment and Learning 
Depending on the results of the initial measurements, namely, according to the 
amplitude and topology of the CNV, EEG-biofeedback sessions are configured subject 
specifically: The training electrode position and the scaling of the feedback are assigned 
accordingly. As defined in chapter 5, learning was accepted to be achieved, if at least 
70% of the trials in successive sessions were successful. Hence, all the control subjects 
(100%) learned to control the SCP at the assigned feedback electrode position. In the 
patient group, learning was achieved in five patients (83%) in one case (i.e, P3GM) not. 
The patient P3GM had strong visual and acoustic cognitive deficits which could not be 
compensated by various configurations of the EEG-biofeedback system.  
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8.7 Application of the Methodology on Sample Cases for Pre- and 
Post-Therapy Comparisons 
Two patients (P2WM and P5RB) were available for the longer follow-up of the applied 
therapy. The developed methodology for therapy evaluation will be demonstrated next 
with these two cases.  
8.7.1 Case I – P2WM 
P2WM is a 47 years old male focal epilepsy patient with complex focal and secondary 
generalized tonic-clonic seizures. He has an intractable epilepsy history of 44 years. 
Focus is diagnosed to be right temporal with interference to the contralateral region. 
The feedback electrode was at the vertex (Cz electrode position) and the training was 
carried out with different feedback types (i.e., visual, acoustic and combined). See 
Table 5-2 for further details. The medication type and doses were kept constant 
through the neurotherapy. Clinical success was achieved in two aspects in this case: 
a. seizure frequency was reduced, b. the patient gained control over the seizures which 
were accompanied by an aura. The results of feature quantification at the central line 
EEG electrodes and the ECG channel are listed in Table 8-7 for all three evaluation 
measurements (evaluation measurement 1 is the pre-therapy measurement) for the case.  
Table 8-7 Results of follow-up for patient P2WM.  
Patient P2WM 
Parameter 
Evaluation Measurement 1 
Electrode 
Evaluation Measurement 2 
Electrode 
Evaluation Measurement 3 
Electrode 
   Fz         Cz        Pz        Oz   Fz         Cz        Pz        Oz   Fz        Cz         Pz        Oz 
DC-hypervetilation 
shv (µV/s) 
-0.50 -0.59 -0.31 -0.37 -0.24 -0.24 -0.13 -0.02 -0.30 -0.45 -0.33 -0.05 
DC-recovery 
srec (µV/s) 
-0.11 -0.07 0.09 0.02 0.41 0.27 0.31 0.14 0.22 0.23 0.21 0.27 
CNV 
dCNV (µV) 
6.67 -1.80 -0.66 11.83 0.56 -14.71 -6.75 4.54 -4.99 -6.09 -1.43 -18.30 
Epileptic patterns 
%Opi 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
IHR 
%HR2rec 
71% 60% Strong artifact in ECG 
channel 
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In this patient, we observed changes in the quantitative parameters of the DC-shifts 
associated with hyperventilation. The measure srec, which had negative values before 
the therapy, has positive values in evaluation measurements in the follow up (compare 
Fig. 8.10 and Fig. 8.18). These results indicate that the recovery, which was not 
observed at the electrode positions Fz and Cz before the therapy, occurs after the 
therapy. 
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Fig. 8.18 DC-shifts during and after hyperventilation at electrode positions Fp1, Fp2, Fz, Cz, Pz, Oz, O1, and O2. 
t = 0, hyperventilation starts; t = 176 s, hyperventilation ends. Patient P2WM, evaluation measurement 3.  
As seen in Table 8-7, the parameter %EPOi is 0.0 for all electrode positions, namely, no 
epileptic patterns were observed in any measurements in this patient. The %HRIhv 
decreases in the second measurement and cannot be computed due to strong artifacts 
in the ECG channel in the third measurement. 
Changes in terms of “normalization” were observed in the parameter of CNV. The 
topological distribution of the measure dCNV is mapped using the same scale for all three 
measurements in Fig. 8.19. When Fig. 8.19 (a), (b) and (c) are compared, the measure 
dCNV, which was hardly observable in the pre-therapy measurement (at Cz=-1,80),  is 
seen to enlarge topologically and becomes more dominant at the fronto-central 
electrode positions in the second (at Cz=-14,71) evaluation measurement. Although it 
becomes less in the third evaluation (at Cz=-6,09) measurement, it is still much higher 
than in the first measurement.  
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Fig. 8.19 CNV results of evaluation measurements in patient P2WM, (a) evaluation measurement 1 (pre-therapy), 
(b) evaluation measurement 2, (c) evaluation measurement 3. 
 
8.7.2 Case II – P6RB  
P6RB is a 33 years old female focal epilepsy patient with focal and generalized seizures. 
The focus is diagnosed to alternate in different measurements (i.e, left and right 
temporal regions). She has 21 years of intractable epilepsy history accompanied with 
organic psychosyndrome and depression. In neurotherapy, the feedback electrode 
position was Fz and the patient was trained with different feedback types (i.e., visual, 
acoustic and combined). See Table 5-2 for further details. In this patient medication 
reduction was achieved. Although fewer seizures were registered, the decrease in 
seizures was not significant. 
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In Table 8-8, results of feature quantification at the central line EEG electrodes and the 
ECG channel are presented for the evaluation measurements. The topological 
distributions of the measure dCNV in different measurements are seen in Fig. 8.20.  
Table 8-8 Results of follow-up for patient P5RB. 
 
Comparing the maps of the measure dCNV, we see that the topology changes in the 
course of the therapy. The frontal dominance at the Fz electrode in the pre-therapy 
measurement moves to te central electrode Cz in the second evaluation measurement. 
In the third evaluation measurement, dCNV is clearly more negative (i.e, higher absolute 
value) again at Fz. The distribution is more circumscribed, with the central and fronto-
central electrode positions in the second and third evaluation measurements, than in 
the pre-therapy measurement.  
Changes in the srec do not conform to our expectations (Table 8-8): the DC-recovery 
becomes slower in all mid-line electrodes in the second measurement. In the last 
measurement, the percentage recovery even becomes significantly negative at the 
vertex. As seen in Table 8-7 (parameter %EPOi), no epileptic patterns were observed in 
the measurements from this patient. The %HRIhv measure, which is 71% in the first 
measurement, decreases to 58% in the second one. In the third measurement, on the 
Patient P5RB 
Parameter 
Evaluation Measurement 1 
Electrode 
Evaluation Measurement 2 
Electrode 
Evaluation Measurement 3 
Electrode 
   Fz         Cz        Pz        Oz   Fz         Cz        Pz        Oz   Fz        Cz         Pz        Oz 
DC-hypervetilation 
shv (µV/s) 
-0.37 -0.40 -0.05 0.46 -0.61 -0.38 -0.04 0.91 -0.45 -0.61 -0.70 -0.81 
DC-recovery 
srec (µV/s) 
0.55 0.59 0.19 -0.90 -0.00 0.14 0.11 -0.34 0.07 -0.13 -0.00 -1.65 
CNV 
dCNV (µV) 
-16.97 -14.16 -1.79 -2.56 -5.50 -17.15 -6.07 17.05 -15.30 -9.42 15.96 4.69 
Epileptic patterns 
%Opi 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
IHR 
%HR2rec 
71% 58% 82% 
8  Results 95 
other hand, it is higher (i.e., 82%) than the first measurement, which indicates a faster 
HR recovery. 
 
Fig. 8.20 CNV results of evaluation measurements in patient P5RB, (a) evaluation measurement 1 (pre-therapy), 
(b) evaluation measurement 2, (c) evaluation measurement 3. 
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9 Discussion 
In the present chapter we will inspect the results of our work, which had several facets. 
It will be helpful to remember that the main objective was to develop a concept and a 
methodology for objective diagnosis, (neuro)therapy planning and evaluation in 
epilepsy. In chapter 3 (section 3.4), we had defined the major components of our 
solution to the problem in terms of biomedical engineering as:  
a. Development of a strategy for objective diagnosis and therapy evaluation,  
b. Data acquisition corresponding to the strategy, 
c. Signal processing for feature extraction and quantification, 
d. Data management. 
It will be our goal to appraise the findings and achievements in these major components 
in a self-critical manner.  
9.1 Clinical Tools for Decision Supporting in (Neuro)therapy 
Evaluation 
The software concept, which has signal analysis (i.e, the neuroprofile extraction 
module) and data management (i.e., the database) parts as main elements, is the first 
step for an automation of the therapy planning and evaluation procedures. The aim is 
increased objectivity in these procedures through quantitative parameters, which are 
structured by the neuroprofile and managed by the database. It must be emphasized 
that the system is not conceptualized as a biomedical signals database, which would 
facilitate the storage of polygraphic signals, or an electronic patient record, but rather  
as a clinical data warehouse that documents the elements of therapies, clinical findings 
and the quantitative results of the analyses applied to the acquired signals of different 
formats (e.g., formats of BrainQuick and NeuroScan systems). 
Although there are nomenclatures and data dictionaries of certain biomedical 
measurements and related data, for instance Vital Signs Information Representation 
(VITAL) by the Technical Committee 251 of European Standardization Committee 
9  Discussion 97 
(CEN/TC251) or the Systematized Nomenclature of Medicine (SNOMED), and 
standard formats for the acquired raw data such as European Data Format (EDF) or 
Extensible Biosignal Format (EBS) for EEG; the efforts for standardization of the 
quantitative parameters extracted from polygraphic signals are restricted to ECG11.  To 
our knowledge, there are no such efforts for the quantitative parameters of EEG signals 
and event-related potentials (e.g., CNV), or for neurotherapy which is an emerging 
unconventional treatment. Therefore, the majority of the objects and attribute 
structures had to be designed specifically in this study.  
As a result of the database development, several aspects arose that need to be 
considered for improvement in the future:  
9.1.1 Refinement of the Data Model 
During the design process, the non-quantitative medical information proved to be more 
complex than expected, and its structuring was not trivial. Some of the medical 
information is stored in verbal phrases. This may suffice for the evaluation purposes of 
one particular person, but it is insufficient for analyses affecting all persons included in 
the database. Fruitful analysis requires the information to be stored in a structured way 
and broken down into manageable quantities, rather than in verbal phrases. This is only 
possible with extensive medical expertise. The refinement of the data model should be 
considered in future versions of the data warehouse. 
9.1.2 Integration of Existing Clinical Databases 
At the current stage, the non-quantitative data have to be entered into the database 
manually, even though they are, at least partially, included in other databases. A 
medical-technical assistant is currently responsible for the task. This fact surely 
complicates the sustainability of the system in the long run, since the physicians in 
clinical practice are not willing to invest much time for data entry. Means of integrating 
the already available information or importing it using standards for health informatics 
                                                         
11 Common Standards for Quantitative Electrocardiography (CSE), which is a part of the Open European 
Data Interchange and Processing for Electrocardiography (OEDIPE) project.  
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should be also considered for the future improvement of the system. Integration of 
existing clinical databases will significantly enhance the long-term sustainability.   
9.1.3 Forming a Normative Database, Data Mining and Decision Supporting  
To gain knowledge not only on a particular person, but of a general nature, a 
representative data stock is necessary. This requires the persons comprising to the 
group to match certain criteria concerning factors such as age, sex, and handedness. 
Such a normative data stock will enable the use of data mining techniques12 for an 
automated discovery of correlations and patterns in vast amounts of existing data, and 
thus, encourage the extraction of hidden knowledge in the stored data. The group of 
control subjects involved in the study is too small to achieve necessary statistical 
prerequisites. Further studies should be conducted to form a normative database. 
Another future vision is the progression of the database to a decision support system 
for an automated therapy evaluation. Via methods of Artificial Intelligence, suggestions 
for therapy adaptation and/or modification can be produced from a set of existing facts 
and insights, and presented to clinical experts. 
9.2 Selected Quantitative Measures 
The prerequisite for any quantitative measure to be accepted as a feature for therapy 
evaluation is that it distinguishes between a certain pathological state and normal 
functioning. The quantitative measures investigated in our work were selected either 
because of their relevance to epilepsy (i.e, percentage occurrence of epileptic patterns) 
or to SCP based neurotherapy (i.e, measures of CNV and hyperventilation induced DC-
shifts). Epileptic patterns are clinically established features, whereas other measures 
had not been previously investigated in this context. Therefore, we had to test the novel 
measures for their applicability, namely, compare them between patients and control 
subjects. Our comparisons indicated statistically significant differences in measure dCNV 
(Table 8-1) as well as measures srec and %DCIrec of hyperventilation induced DC-shifts 
(Table 8-4). Although the measures of changes in the IHR during hyperventilation also 
                                                         
12 A comprehensive overview on current data mining techniques can be found in http://damit.dfki.de/. 
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indicate differences between patients (Table 8-5) and controls (Table 8-6), conclusions 
cannot be drawn from the results for these measures. Nevertheless, the method, in 
which srec is plotted versus %HRrec/hv (Fig. 8.16), and %DCrec verus %HRIhv (Fig. 8.17) 
demonstrate the usefulness of integrating the quantitative IHR measures in the analysis 
for comparisons between patients and controls.  
The findings of comparisons between patients and controls are primarily useful for 
diagnostics. Going a step further, we tested and demonstrated the application of our 
methodology and measures for pre- and post-therapy comparisons in those patients, 
who were available for longer follow-up (section 8-7).  
Changes in the measures dCNV and %DCIrec, which can be considered as “normalization”, 
are observed in a single case (Case I, section 8.7.1). In the second sample case (Case II, 
section 8.7.2), however, the results did not conform to those of Case I or to our 
expectations. The measure %DCIrec, which was positive in the pre-therapy measurement 
(i.e., recovery occurs), became less in the second evaluation measurement and was even 
negative (i.e., no recovery) in the third measurement. These two sample cases are 
insufficient to derive conclusions. Measurements and follow-up studies on new 
epilepsy patients with a successful neurotherapy history are required for conclusions 
based on statistical significance. The recruitment of a statistically significant number of 
patients exceeds the scope of the current work, since, neurotherapy, as an 
unconventional treatment does not yet have priority in the list of treatments, and 
health insurance regulations prevent the compensation of the costs of the novel 
treatment if a person is an outpatient. Therefore, the patients had to agree to cover their 
own expenses for the training and evaluation measurements in the follow-up period, in 
which they were outpatients.  
Nevertheless, future data related to such measurements from new patients and/or 
healthy controls can be analyzed using the methods developed in the current work, and 
the quantitative results can be integrated into the data warehouse without any exertion 
for further statistical comparisons. Yet, it is not until all the substantial components of 
the neuroprofiles (e.g., additional measures related to odd-ball or photostimulation 
measurements – see chapter 4, section 4.2) are entered into the database that the 
information can be extensively exploited for diagnostics and therapy evaluation. The 
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extension is a long-term process involving several clinical studies. This process will be 
hastened by automation through the mathematical and software tools developed (i.e., 
neuroprofile, neuroprofile extraction module, and the database system). 
Next, the selected measures will be discussed more in detail. 
9.2.1 Graphoelements 
The performance of the features for epileptic pattern extraction is tested on a set of 
randomly chosen epileptic patterns from data acquired in previous studies. In these 
comparisons, the new feature, FD, proved to perform superiorly to the previously used 
VM. Although epileptic patterns in EEG are considered clinically more established 
features in epilepsy, we did not commonly observe such activities in our measurements. 
This is probably due to the fact that such patterns are infrequent in focal epilepsy 
patients, who are considered to be more suitable for neurotherapy. The measure %EPOi 
should be reserved as a quantitative parameter for those cases, in which such patterns 
are observed. 
9.2.2 Contingent Negative Variation 
The quantitative parameter dCNV shows significant differences in amplitude and 
topology between the patients and controls (Table 8-1). This information can be used 
for diagnostics as well as therapy evaluation. In case P2WM, changes in this parameter 
were observed in the follow up (Table 8-7 and Fig. 8.19). in order to be statistically 
significant, data from further patients with a successful history of neurotherapy are 
necessary.  
9.2.3 Hyperventilation Induced DC-Shifts in EEG and Changes in IHR 
Although hyperventilation is used as a provocation to induce epileptic discharges in 
clinical examinations, the accompanying DC-shifts had not been considered for their 
potential diagnostic relevance. The results presented in this study indicate differences 
in the hyperventilation induced DC-shifts between patients and controls especially in 
the recovery process (i.e., percentage recovery) (Table 8-4). In 3 patients (50%), the 
recovery is not observed at the vertex, whereas in the remaining three patients the 
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percentage increase in the DC-level is much higher than the average of the control 
group. These differences can be exploited for diagnostics and therapy evaluation. In 
terms of therapy evaluation, the results obtained are restricted to the single case 
P2WM. The lack of recovery in P2WM in the pre-therapy measurement was observed 
in the follow up (Table 8-7). 
The observation, that in 3 controls (50%) and 2 patients (33%) the hyperventilation 
induced DC-shifts are in positive direction in occipital electrodes, provokes the 
question of whether hyperventilation builds a dipole (or amplifies an already existing 
one, frontal being negative and occipital being positive) in the brain. This observation 
also needs further investigations.  
In the clinical practice, there is no quantitative monitoring of the rate of 
hyperventilation. The instruction given to the patients is that they have to breathe 
deeper with approximately the same number of cycles per minute. The subject is 
motivated to continue three minutes of hyperventilation with further instructions 
during the process. In order to have a reference for the changes in the vegetative 
functions, the percentage changes in the average IHR is assigned in this study. The 
parameters of IHR are commonly accepted parameters for autonomous physiological 
functions.  
The approach, in which the changes in IHR are additionally considered parallel with 
the changes in the DC potentials during hyperventilation and recovery, is unique in its 
form. The main aspect of the IHR analysis in a provocation such as hyperventilation is 
quantification of the changes in the autonomous functions. Accordingly, changes in 
brain activity and changes in the autonomous functions can be monitored 
simultaneously. Our results (Fig. 8.16, Fig. 8.17) demonstrate the benefits of the 
approach in a neurological disorder such as epilepsy. Integration of different 
quantitative parameters for the changes in the IHR (i.e., %HRrec/hv and %HRIhv) adds a 
new dimension to the analysis. In Fig. 8.16, the patients can be distinguished from the 
controls by the parameter %HRrec/hv . In Fig. 8.17, two groups of patients, one with no DC 
recovery  at the vertex (i.e., PT1), and the other with a very high percentage DC 
recovery (i.e., PT2), can be recognized. The control subjects, on the other hand, form 
another cluster between the two patient clusters (i.e., CS). There is a fourth cluster 
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(i.e., OG) with two members (a patient and a control subject). However, defining a 
zone between %DCIrec values of, for instance, 30%-130% we can distinguish the controls 
clearly from the two patient groups. These results suggest a “normal zone” in the 
corresponding plot. This issue also needs further investigations in larger groups of 
controls and patients. 
In our method of quantifying the changes in IHR, we used first-order statistical 
parameters; higher order analysis should be considered for describing the dynamics of 
the changes in future investigations. Similarly, the presented results of parallel analysis 
of the DC-shifts and the IHR are for a single EEG channel (i.e., Cz, the vertex), at which 
the highest DC-shifts are commonly observed. Nevertheless, changes at the other EEG 
channels can be integrated into the analysis via multivariate statistics. Such a statistical 
analysis task is beyond the scope of the current study and should be addressed in a 
study concentrating mainly on this issue. 
Electrode stability is another critical issue in DC measurements that needs discussion. 
There is a strong debate on whether or not such DC potentials are measurable by the 
surface electrodes. It must be underlined that DC measurements are, indeed, very open 
to movement artefacts. On the other hand, the very specific patterns we observe in our 
measurements (i.e., triggered by stimuli S1 and S2 in CNV measurements, and by 
hyperventilation) cannot be considered and explained via artefacts. A more detailed 
discussion on sources of error in such measurements can be found in [67]. 
Another proposal for further research is the utilization of a quantifiable provocation 
method such as oxygen stimulation instead of hyperventilation. The method, in which 
the partial pressure of the applied oxygen can be assigned as a quantitative parameter, 
will be more efficient, since the comparability of the results will be increased. 
Subsequently, effects of oxygen stimulation on both IHR and the DC-shifts could be 
examined with the methods of the current work in different patient and control groups. 
Such a method would also reduce the possible movement artifacts encountered during 
hyperventilation. 
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9.3 Quantification of Learning 
In this study, the subjects, or respectively the patients, are defined to have learned the 
self-regulation of SCP, if a success rate of 70% was achieved in distinguishing between 
the two tasks (i.e., negativation and positivation) in the training sessions. This is a 
sufficient definition for the current state of research in EEG-biofeedback. Nevertheless, 
a more detailed analysis of learning and its quantification should be addressed 
additionally as a separate study in the future. Consequently, correlates between the 
measures introduced in this study and the quantitative parameters of learning at 
different stages (see section 5.3) could be investigated.  
9.4 Understanding Neurotherapy 
In the course of clinical applications with epilepsy patients as well as laboratory 
studies with the controls, we encountered several phenomena which need discussion: 
a. During the neurofeedback training process, the “intuitively” evolved varying 
respiration patterns correlated to the DC-shifts recorded on the scalp. The 
control of the DC-shifts, however, is not sustained via respiration feedback. An 
interaction between the SCP generated upon neurofeedback process and the 
respiration patterns was observed. The spectral power of the respiration curves 
was higher during the task of negativation than during the task of positivation 
(Fig. 9.1) [67], [109]. 
b. The SCP can be distorted by the spreading of the changes in the eye-potentials 
caused not only by slow eye and head movements, but also by the lack of light 
adaptation. These sources of error must be monitored during a neurofeedback 
process [67]. On the other hand, a similar pattern (excluding the artifacts due to 
ocular movements) is observed in the VEOG during the generation of CNV in 
the modified S1-S2 paradigm.  
c. Application of acoustical or visual stimuli for the S1-S2 paradigm results in 
differences in the topological distribution of the resulting variations in the 
SCPs [110]. Visual and acoustic components do not influence the process in the 
same manner.  
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Fig. 9.1 Results of an EEG-biofeedback session based on SCP (black: negativation task, red: positivation task), 
(a) feedback channel Fcz, (b) respiration channel ATHM, and corresponding spectral power of the 
respiration channel (c) negativation task, (b) positivation task. © RGESIM/ASIM Verlag-Proceedings of 
World Congress on Neuroinformatics. 
These observations indicate that the complex interactions between the higher CNS 
functions, such as perception and information processing, and vegetative physiological 
functions of the body, such as respiration and heart beat, are crucial in the 
(a) 
(b) 
 
(c) (d) 
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neurofeedback process.  These functions are inseparable in the context of training 
self-regulation.   
The CNS not only has a higher regulatory task to coordinate the functional subsystems 
of the body as a whole system, but is itself a functional part of it, and depends on these 
subsystems. Therefore, the process of neurotherapy cannot be considered as simply an 
extra feedback loop to the brain. Furthermore, analyzing a complex process (i.e. the 
neurofeedback) which causes changes on a very complex system (i.e., the nervous 
system) exceeds the borders of conventional system analysis approaches. 
9.4.1 Changing the Paradigm 
The traditional control engineering approaches to the systems are mainly based on the 
assumption of a “closed system”. In the recent decades, this approach has been seriously 
debated, especially when the system considered has a biological nature. The “openness” 
of biological systems was first stated by the biologist von Bertalanffy [111]. In terms of 
thermodynamics, open systems are those which exchange energy, matter, and 
information with their environment. Energy and matter can enter or leave the system or 
be stored in a storage element (i.e., memory). Inside the system, they can interact with 
each other. Living systems are open systems exchanging energy, matter and information 
with their environment, thus maintaining their structures and functions.  
Following these notions, we consider the human physiology, as well as the nervous 
system, as a complex adaptive open system. Mainzer [112] states that the complex 
system approach offers the possibility for modeling the neural interactions of the brain 
processes on the microscopic scale and the emergence of the cognitive structures on the 
macroscopic scale. Thus, it seems to be possible to bridge the gap between the 
neurobiology and the cognitive sciences of the mind, which traditionally has been 
considered an unsolvable problem. 
Neurotherapy intervenes in the CNS at a macroscopic level: We do not go down into 
the system to the level of neuronal interactions, but we use a macroscopic level 
parameter; a parameter extracted from EEG (e.g., the DC-level).  
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Our observations suggest that the neurofeedback process intervenes in this “gap”, at a 
“mesoscopic” level. The neurofeedback process involves the interactions between the 
psychological and neurobiological processes. We consider the extracted EEG 
parameter used for the feedback as a parameter of the “mesoscopic” level (i.e., an 
interface level) between the psychological (the macroscopic level) and neurobiological 
levels (the microscopic level):  
Psychological processes  >  MACROSCOPIC LEVEL 
Extracted EEG parameter  > MESOSCOPIC LEVEL 
Neurobiological processes  > MICROSCOPIC LEVEL 
The definition of a certain level as being microscopic, mesoscopic or macroscopic is 
relative. The defined mesoscopic level is a microscopic level with respect to the 
psychological level, and at the same time a macroscopic level with respect to the level of 
neurobiological processes. These levels can be regarded as representing the instability 
hierarchies [10].  
Another property of natural systems is that they are self-organizing. Self-organization 
at the microscopic level is considered to be the fundamental mechanism of spontaneous 
pattern formations at the macroscopic level in open systems, which are far from 
equilibrium.  
9.4.2 Self-Regulation and Self-Organization 
According to Schwartz [113], the concept of self-regulation is fundamental to behavior 
therapy, and the main adaptation mechanisms in living systems. It is, in this sense, not a 
coincidence that EEG-biofeedback is also referred to as cortical self-regulation (though 
it is not clear whether only cortical structures or many others are involved in the 
process). A self-regulating system is able to maintain its essential variables within 
limits acceptable to its own structure in case of unexpected disturbances. This can only 
be achieved through feedback mechanisms which detect disturbances, and accordingly 
activate (positive feedback loops) or inhibit (negative feedback loops) the related 
subsystems. To our understanding, self-regulation and self-organization are two highly 
interrelated phenomena, which are both determined by the nonlinear interactions at 
the microscopic level.  
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9.4.3 EEG-Biofeedback and Non-Linear Phase Transitions 
Many processes of coordination and regulation in human physiology involve phase 
transitions with nonlinear and non stationary properties, so does SCP based 
neurofeedback. The results of a training session, in which the tasks of negativation and 
postivation are successful (Fig. 9.1), indicate non-linear phase transitions to these two 
states. Such spontaneous phase transitions are commonly observed where a system 
changes its macroscopic state qualitatively [114]. For phase transitions of systems in 
thermal equilibrium the adequate treatment of fluctuations could be solved by 
renormalization group techniques. However, for systems far from thermal equilibrium 
(i.e., non-equilibrium phase transitions), the phenomena and the problem get more 
complex, and need novel approaches.  
9.4.4 Concepts of Synergetics 
Synergetics, as pioneered by Haken [9], [10], offers a theoretical framework for the 
self-organization phenomenon giving rise to emergent new qualities at the macroscopic 
level, and analyzing non-equilibrium phase transitions via the concepts of control 
parameters, order parameters, slaving principle and circular causality. In synergetics, 
the circular causal relations between different levels are explained via order parameters 
and the slaving principle. 
A control parameter is a parameter which is defined to be controlling the macroscopic 
behavior of a system. The critical value of a control parameter leads to a bifurcation in 
system behavior [115]. 
An order parameter is defined as a descriptor of the system at the macroscopic level. 
Referring to [116]:“When one, or maybe several control parameters are changed, the system enters 
instability. In other words, it leaves its former state and starts to form a qualitatively new macroscopic 
state. Close to the instability point, different kinds of collective configurations occur; some of them grow 
whereas others decay after generation by fluctuations. By a study of growing and decaying states, we 
may distinguish between the unstable and stable configurations and are thus led to configurations which 
are governed by the order parameters. The order parameters determine the behavior of the individual 
parts via the slaving principle. Thus the behavior of complex systems can be described and understood in 
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terms of order parameters. At the same time, we need no longer to consider the action or behavior of the 
individual parts, but may instead describe the total system by means of the order parameters.” 
The slaving principle states that not only the behavior of the growing configurations, but 
also that of decaying configurations is uniquely determined by the order parameters 
which give rise to compression of information needed to describe the behavior of the 
system. The principle of circular causality defines the causality between the order 
parameters and the behavior of the components (i.e, sub-systems) of a system. The 
individual parts of the system cooperatively determine or generate the order 
parameters, which in turn enslave the individual parts. Enslavement and consensus 
finding can be regarded as similar principles [117]. 
9.4.5 Neurotherapy as a Process of Learning: Operant Conditioning and 
Coordination 
EEG-biofeedback is a process of learning. In terms of psychology, it is defined as an 
operant conditioning. At the microscopic level, according to the widely accepted 
hypotheses of Hebb [118], learning is explained through strengthening synapses 
between the neurons, which are repetitively activated simultaneously. Hebb also 
suggests that learning should be understood as a kind of self-organization in a complex 
brain model. At the macroscopic level, we encounter the studies in behavioral 
psychology regarding different forms of conditioning. From the systems analysis point 
of view, synergetics offers a theoretical framework and tools for analyzing a process of 
learning via the effects of the learning process on the order parameters of a system.  
According to [119], there may be several mechanisms by which the motion patterns 
described by the order parameters can change upon learning: 
a. The dynamics of the order parameters may change in that the potential 
landscape undergoes a transition. 
b. New order parameters may emerge by means of the cooperation of old order 
parameters. 
c. New order parameters may emerge from the microscopic parts as a consequence 
of changes in the control parameters at the microscopic level. 
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An important example of analyzing an operant conditioning process with the methods 
of synergetics is the pedalo experiment [120], in which the movement patterns of the 
subjects are analyzed during the process of learning to drive a pedalo. In this example, 
it is demonstrated that as learning proceeds, fewer and fewer degrees of freedom 
dominate the movement pattern , and that, eventually the movement is governed by a 
single complex order parameter.  
Although the EEG-biofeedback process is not concerned with motor movements, there 
are analogies to the pedalo experiment in terms of learning a specific “coordination” of 
the involved subsystems. In the pedalo experiment, the subsystems are motor units 
such as parts of the arms and legs which are under our voluntary control, whereas in 
the EEG-biofeedback process, these subsystems are units of the higher CNS functions 
involving the cognitive functions, and the autonomous nervous system such as 
respiration and heart beat. The analogies are that: 
a. As a result of the learning process, a new specific coordination is achieved 
among the subsystems in both cases. 
b. This new coordination can be recalled and activated by the subject when the 
corresponding situation is encountered (e.g., control of seizures in case of aura). 
9.4.6 Is the DC-level an Order Parameter of the Brain Complex Open System? 
Several characteristics of the DC-level or shifts in the DC-level suggest that it can be an 
order parameter of the brain as a complex open system [121]: 
Switching role of orders parameters and the DC-level 
According to the synergetical approach, the critical value of a control parameter may 
lead to a bifurcation where order parameter may play a switching function between 
two (or more) possible states [122]. The results of SCP-based neurofeedback (Fig. 9.1) 
can be considered as switching from a less excitable state to a more excitable one or 
vice versa. Also in the S1-S2 paradigm, the changes (Fig. 8.6) can be similarly 
interpreted.   
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Order parameters are long lasting 
The DC-level is preserved until the introduction of the succeeding stimulus in CNV 
(Fig. 8.6) and in the neurofeedback session (Fig. 9.1). This observation suits the 
property of order parameters being long-lasting. 
Governing role order parameters 
The observation that the respiration patterns may differ during the tasks of 
negativation and positivation (Fig. 9.1) and that the voluntary DC-regulation is not 
achieved by respiration feedback suggests the governing role of DC-level over other 
sub-systems (i.e., in this case, functions of  the autonomous nervous system). 
An order parameter is a descriptor of the system at the macroscopic level 
Referring to the definition of Caspers [44] that a DC-shift is an indicator of the cortical 
excitability changes, with a negative shift showing an increased cortical excitability, 
and a positive shift a decreased one, and to the different states (i.e., sleep-wake cycle, 
seizure activity, information processing, hyperventilation –see chapter 2, section 2.3.3 
for details) in which DC shifts are observed, the DC-potential shift can be defined as a 
descriptor of the brain at macroscopic level.  
One cannot claim that the DC-shifts observed at various states share the common 
origin and generation mechanism without investigating their correlates (i.e., control 
parameters) at the microscopic level. As explained in chapter 2, there is no consensus 
on the origin(s)/generator(s) (i.e., neurons, glial cells, blood brain barrier and cerebral 
blood flow) and generation mechanism(s) of the DC potentials. However, at the 
macroscopic level, the concept of order parameter gives us a tool to consider these 
DC-shifts observed at different states together, since there is a circular causal 
relationship between the DC-level and the microscopic level: The microscopic level 
generates the DC-level, which in turn determines the excitability of the microscopic 
level, and excitability is a measure of firing rate at the neuronal level. 
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9.4.7 Neurotherapy: An Interface of Psychology and Neurology via Synergetics? 
Considering the brain as an open system interacting with other subsystems of the 
human physiology and analyzing these interactions allows for new insights. Following 
this paradigm, we can analyze simultaneous changes in the observables of processes 
participating in neurofeedback, which appear not to be limited to the observables of 
the brain functions. Excluding the higher macroscopic level psychology, Fig. 9.2 
illustrates a synergetic representation of microscopic and macroscopic levels and the 
corresponding parameters. 
 
Synergetic effects on the 
macroscopic level
Control parameters
pCO2, pO2,pH, light intensity, anaesthetic chemicals, information …
Order parameters (Macroscopic level)
DC-level, frequency powers, phase ...
Microscopic level 
Neurons, glial cells, blood brain barrier ...
Enslaving Self-organization
Dynamical pattern
(EEG)
 
Fig. 9.2 Synergetical representation of microscopic and macroscopic interactions, and corresponding parameters. 
Psychology as a higher macroscopic level is excluded for simplification.  
The control parameters can be external as well as internal parameters. They define the 
nature of interactions at the microscopic level. Examples of external control parameters 
can be the intensity or frequency of an acoustic or visual stimulation, whereas 
hormones or ional concentrations can be regarded as internal control parameters. A 
control parameter can also be an abstract quantity such as information, as in the case of 
CNV, where S1 in the paradigm carries the information of a “warning” for the 
succeeding aversive or non-aversive stimulus S2.  
The above discussions and considerations provide us with a theoretical framework at 
the system level, which enables a deeper understanding of the neurotherapy process, 
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and accordingly its diverse influences on human physiology, which shall be investigated 
further in future studies.  
 
10 Summary and Conclusion 
… 
Wär nicht das Auge sonnenhaft, 
Die Sonne könnt es nie erblicken; 
…13 
 
Johann Wolfgang von Goethe 
1749, Frankfurt (Main) – 1832, Weimar 
 
 
The verb “to see” has a second meaning in many languages like it has in English, namely, 
“to understand.” As Goethe describes using the eye, probably as a metaphor, there is the 
need of a property of “seeing” that matches to its object of interest. Similarly, there is 
the need of a matching paradigm to phenomena analyzed in the scientific context. 
The present work includes several aspects spanning from engineering over neurology to 
psychology. The main contributions and insights of this interdisciplinary work towards 
an automated objective (neuro)therapy planning and evaluation in epilepsy can be 
summarized as follows: 
After a systematic overview of conventional methods and procedures of diagnosis and 
therapy evaluation, EEG-biofeedback protocols proposed for epilepsy were elucidated 
with an emphasis on slow cortical potentials based neurotherapy. The problem analysis 
pointed out that the diversity of cases, the variety of treatment modalities, and the lack 
of quantitative features complicate the objectivity in therapy planning and evaluation. 
In order to increase the objectivity, a concept and a methodology were developed by 
introducing: 
a. An evaluation measurement protocol which brings a standardization to the 
diagnosis and evaluation procedures; 
                                                         
13 Farbenlehre, The Divine is Spread Everywhere. …/ If the eye were not sun-like/ how could it ever spy 
the sun?/… 
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b. The neuroprofile as a concept and a tool for defining a structured set of 
quantifiable measures which can be extracted from electrophysiological 
signals; 
c. A set of novel quantitative features (i.e., sub-set of the components of the 
neuroprofile) extracted from EEG (or, respectively, ERP) and ECG: 
i. Percentage epileptic pattern occurrence (EPO), 
ii. CNV level difference measure (dCNV), 
iii. Direct current recovery index (DCIrec), 
iv. Heart rate recovery ratio (HRrec/hv), 
v. Hyperventilation heart rate index (HRIhv); and 
d. A software concept and the corresponding tools (i.e., the neuroprofile 
extraction module and the database) to support the methodology as a basis 
for automation.  
The measurement protocol was applied to voluntary control subjects, and to epilepsy 
patients, who received neurotherapy as a complementary treatment to pharmacological 
therapy. The features introduced were investigated on these real data.  
The EPO was extracted via methods of supervised and unsupervised epileptic pattern 
quantification. The corresponding adaptive segmentation algorithm was modified by 
introducing fractal dimension (FD) as a new feature for pattern characterization. 
According to our results, FD was observed to be superior to the previously used Värri 
measures in extracting epileptic patterns. 
Analyzing the CNV acquired via a modified S1-S2 paradigm, and assigning dCNV as the 
quantitative parameter, statistically significant differences were determined between 
the epilepsy patients and the healthy controls.  
Changes in the EEG/DC-level were analyzed during and after hyperventilation, which 
is a commonly used clinical activation method to provoke epileptic patterns. 
Differences between patients and controls were determined, especially in the recovery 
process (i.e., in the quantitative measure srec defined in this study). Using the new 
measures shv and srec, the DCIrec was defined.  
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The simultaneously acquired ECG signals were additionally analyzed during and after 
hyperventilation for extracting IHR curves. Three quantitative parameters HRbsl, HRhv, 
and HRrec were calculated. Using these parameters, two indices were assigned for 
quantifying the hyperventilation induced changes in ECG: the HRrec/hv and the HRIhv.   
The method, in which the measures of hyperventilation induced changes in IHR were 
integrated to hyperventilation induced DC-shifts in EEG, is unique in its form. Our 
results indicate the utility of the method in distinguishing the epilepsy patients from 
the healthy controls. These findings are important, primarily in terms of diagnostics.  
Going a step further, we demonstrated our methodology for therapy evaluation on two 
sample cases, which were available for longer follow-up. Changes were observed in the 
assigned new measures in sample cases. This is not sufficient to base conclusions on 
whether or not the observed changes resulted from neurotherapy. Further clinical 
studies on new epilepsy patients with a successful neurotherapy history are required 
for such conclusions.  
Nevertheless, the data to be acquired in future studies can be integrated into the 
analysis without much exertion via the developed tools in this study: The defined 
measures can be extracted by the neuroprofile extraction module and stored in the 
developed database for further statistical investigations.  
Based on the observations we gained in the course of EEG-biofeedback sessions, we 
discussed the necessity of a change in paradigm for understanding neurotherapy. 
Neurotherapy (i.e. EEG-biofeedback) is a complex process in which not only cognitive 
functions, such as perception and information processing, but also vegetative functions, 
such as respiration and heart beat, are involved. This process elicits alterations to the 
human nervous system and physiology as a whole system. Therefore, it cannot be 
regarded as a simplified control feedback loop as in the analysis of closed systems. 
Hence, referring to Goethe once again, changing the paradigm is inevitable in order to 
comprehend neurotherapy. The novel paradigm should comply with the intrinsic 
complexity of the human physiology as well as that of the neurotherapy process.  
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As a process of learning, neurotherapy has analogies to the operant conditioning 
experiments analyzed in the realm of synergetics. A synergetical approach can provide 
further tools for understanding the dynamics of the neurofeedback process at a 
macroscopic level. Accordingly, the process of neurotherapy can be regarded as learning 
a specific coordination of cognitive and autonomous physiological functions. Such an 
analogy results in further tasks such as determining the accurate control and order 
parameters of the neurofeedback process and quantifying them. The DC-level and its 
behavior show the properties of an order parameter at the macroscopic level. 
The theoretical framework of synergetics leads us to investigating parameters of 
interactions between different sub-systems of human physiology, which are not 
necessarily considered to be interrelated in the context of neurotherapy or epilepsy, 
such as the interactions between higher cognitive functions and the autonomous 
nervous system. Future research in the field should be concentrated on these 
interactions. Knowing that such an approach might not be comprehensible to 
conventional thinking, it will be appropriate to end with a citation from the English 
poet Francis Thompson describing the interconnectedness of the macroscopic and 
microscopic levels:  
All things by immortal power 
Near or far 
Hiddenly 
To each other linked are, 
That thou canst not stir a flower 
Without troubling a star. 
 
Francis Thompson 
1859, Preston Lancashire – 1907, London 
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FRAGEBOGEN        
 
Name, Vorname        :                                       
Geburtsdatum            :                                                       
Geschlecht                 :    weibl.                               männl. 
Sonstiges                    :  Größe                 m             Gewicht                   kg 
Adresse Info (Email)  : 
Telefonnummer        : 
Beruf / Studium (Richtung): 
Tag der GrM1: Tag der GrM2: Tag der GrM3: 
 
Händigkeitstest: 
Zähne putzen     links         rechts Tennisschläger halten  links                      rechts 
Würfeln     links         rechts Messer u. Gabel halten  links                      rechts 
Blumen gießen 
(kl.Kanne)      links         rechts Essen  links                      rechts 
Schreiben     links         rechts Korkenzieher halten  links                      rechts 
 
Haben Sie schon einmal unter einer der folgenden Krankheiten/Funktionsstörungen gelitten? 
Herzerkrankungen  ja, wann?                                                                        nein 
Anfälle (allgemein)  ja, wann?                                                                        nein 
Kopfverletzung in der Vergangenheit  ja, wann?                                                                        nein 
Gedächtnisschwierigkeiten  ja, wann?                                                                        nein 
Attention Deficit Hyperactivity Disorder 
(ADHD) 
 ja, wann?                                                                        nein 
Attention Deficit Disorder (ADD)  ja, wann?                                                                        nein 
Depression  ja, wann?                                                                        nein 
Lernbehinderung  ja, wann?                                                                        nein 
Schlaganfall  ja, wann?                                                                        nein 
Hirnhautentzündung  ja, wann?                                                                        nein 
Durcheinander, Halluzinationen  ja, wann?                                                                        nein 
visuelle Erkrankungen (Brillenträger?)  ja, was?                                                                           nein 
Sonstige was/wann?                   __________                                     
 
Nehmen Sie zur Zeit Medikamente? 
 ja, was/wie viel?                                                           nein 
 
Haben Sie gestern geschlafen? 
 ja, wie lange?                                                                 nein 
 
Welche Genußmittel gebrauchen Sie? (freiwillig antworten) 
Alkohol  ja, was/wie viel?                 nein    keine Antwort 
Nikotin   ja, was/wie viel?                 nein    keine Antwort 
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Technische Universität  Ilmenau 
Institut für Biomedizinische Technik und  Informatik 
 
 
Name, Vorname  
Referenz-ID  
Geburtsdatum  
Geschlecht  weibl.               männl. 
Status  Patient             Proband 
Händigkeit   rechts              links                      beidseits 
 
 
 
 
 
 
Anamnese 
 
 
 
 
Familienanamnese 
(für relevante Erkrankungen) 
 
 
 
 
 
 
 
 idiopathisch    symptomatisch      kryptogen 
 fokal               generalisiert         nicht klassif. 
Region: 
Elektrodenposition: 
 
Diagnosen 
 
 
 
 
 
- Epilepsietyp 
– Epilepsieklassifikation 
- Epilepsieherd 
    (wenn focal, wo?) 
 
- Andere 
  (welche?bitte spezifizieren) 
 
 
 
 
 
 
Anfallstyp 
 visuell             akustisch         motorisch  
 keine              andere (welche?) 
 keine Aura vor Anfall  
 Aura vor Anfall? Aurabeschreibung: 
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Symptombeschreibung eines 
Anfalls 
 
 
 
 
 
 
 
Photosensibilität  ja                                   nein 
Beschreibung: 
 
 
 
 
 
 
 
 
 
 
 
Therapie 
– neurochirurgisch (Datum) 
 
 
 
– andere (welche?/ von-bis) 
 
 
 
 
 
 
Messungen 
 – EEG (Datum / Befund) 
 
 
 
 
 
 
 
Messungen 
 – Andere (CT, EKG...) 
                        (Datum / 
Befund) 
 
Neurologisch     ja                      nein 
Psychologisch    ja                      nein 
Besonderheiten / 
Auffälligkeiten 
 
  
 
 
 
 
Psychol.Beurteilung des Pat. 
(bezügl.Wahrnehmung 
u.Gedächtnis) 
 
 
 
Datum: _____________           Unterschrift:_________________________
 
 Technische Universität  Ilmenau 
Institut für Biomedizinische Technik und  Informatik 
 Medikation                               Patient:                                     geb.:  
 
Einnahme Dosierung Blutspiegelkonzentration Medikament 
von bis früh mittag abend nachts Datum Befund 
Nebenwirkungen 
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
Datum:  ____________________________                 Unterschrift: ______________________________  
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Thesen (Statements in German) 
1. Neurotherapie (bzw. EEG-Biofeedback) ist eine komplementäre unkonventio-
nelle Behandlung, die bei Erkrankungen, welche im Zusammenhang mit 
Regulationsproblemen des Zentralnervensystems stehen, angewandt wird. 
2. Epilepsie ist eine komplexe neurologische Erkrankung, die auf biochemischer 
und physiologischer Ebene nicht ausreichend geklärt ist.  
3. Die objektive Validierung der neurotherapeutischen Wirksamkeit ist eine der 
wichtigsten Aufgaben des Forschungsgebietes. 
4. Die Vielfalt der epileptischen Krankheitsbilder und der Behandlungs-
modalitäten verursacht ein Defizit von quantitativen Validierungskenngrößen, 
die die Objektivität und die Effizienz der Diagnose und der Therapieevaluierung 
signifikant erhöhen können. Dies trifft sowohl auf die Neurotherapie, als auch 
auf konventionelle Behandlungen zu.  
5. Eine höhere Objektivität kann durch folgende vorgeschlagenen 
komplementären Komponenten erreicht werden: 
a. Ein für die klinische Routine anwendbares Messprotokoll, welches einen 
standardisierten Ablauf  und Vergleich ermöglicht; 
b. Das Neuroprofil als ein signalanalytisches mehrdimensionales Modell, 
welches einen strukturierten Satz quantifizierbarer Kenngrößen definiert, 
die von elektrophysiologischen Signalen extrahiert werden können; 
c. Ein Satz von neuartigen quantitativen Kenngrößen, die aus dem 
Elektroenzephalogramm, den ereignisbezogenen Potentialen und dem 
Elektrokardiogramm  berechnet werden. Folgende Kenngrößen werden 
vorgeschlagen:  
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i. Prozentuale epileptische Musterhäufigkeit: Percentage epileptic pattern 
occurence (EPO); 
ii. Maß des Niveauunterschiedes der kontingent negativen Variation: 
Contingent  Negative Variaton  level difference  measure (dCNV); 
iii. Index der Gleichspannungsänderung während und nach 
Hyperventilation: Direct current recovery index (DCIrec); 
iv. Quotient der Herzschlagfrequenzänderung während und nach 
Hyperventilation: Heart rate recovery ratio (HRrec/hv); 
v. Index der Herzschlagfrequenz bei Hyperventilation: Hyperventilation 
heart rate index (HRIhv). 
6. Es wurden deutliche Unterschiede in den Datenparametern dCNV, DCIrec, HRrec/hv 
von Epilepsie-Patienten und Probanden festgestellt. 
7. Die Kombinierung von Kenngrößen des Elektroenzephalogramms (DCIrec) und 
Elektrokardiogramms (HRIhv, HRrec/hv) unterstützt die Diskriminierung der 
Patienten und der Probandengruppe.  
8. Die prozentuale epileptische Musterhäufigkeit (EPO) wurde mit Hilfe der 
Methoden der überwachten und nicht überwachten Mustererkennung 
ermittelt. Der dazu gehörige adaptive Segmentierungsalgorithmus wurde 
modifiziert, indem die bislang verwendeten Värri-Parameter durch den 
nichtlinearen Parameter Fraktaldimension ersetzt wurden. Es wurde 
festgestellt, dass die Fraktaldimension die epilepsiespezifischen Änderungen 
des Elektroenzephalogramms, wie z.B. die epileptischen Graphoelemente, 
effektiver beschreibt und damit die Segmentgrenzen präziser ermittelt werden 
können.  
9. Die entwickelten Software-Tools, das Neuroprofilextrahierungsmodul und die 
Datenbank „Neurobase“, bilden eine Basis zur Automatisierung der Prozeduren 
für die Diagnose und Therapieevaluierung. 
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10. Die Neurotherapie ist ein komplexer Lernprozess, bei dem höhere kognitive 
Funktionen sowie das autonome Nervensystem beteiligt sind. Die Synergetik 
bietet einen geeigneten theoretischen Rahmen für die Analyse der an einem 
solchen Lernprozess beteiligten physiologischen bzw. psychophysiologischen 
Subsystemen auf einer  makroskopischen Ebene. 
11. Basierend auf den gewonnenen Erkenntnissen wurde die Hypothese aufgestellt, 
dass das Gleichspannungsniveau im Elektroenzephalogramm ein Ordnungs-
parameter des Gehirns ist, wobei das Gehirn als ein komplexes offenes System 
betrachtet wird. 
12. Diese Hypothese sowie die Wechselwirkungen zwischen der höheren 
kognitiven Tätigkeit und dem autonomen Nervensystem sollten Gegenstand der 
zukünftigen interdisziplinären Forschung auf den Gebieten Signalanalyse, 
Systemtheorie, Epilepsiediagnostik und Neurotherapie sein. 
